Title: Can nonalcoholic beer, silicon and hops reduce the brain damage and behavioral changes induced by aluminum nitrate in young male Wistar rats?
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20180801
Title: Canagliflozin prevents scopolamine-induced memory impairment in rats: Comparison with galantamine hydrobromide action.
Journal: Chemico-biological interactions 20171101
Title: Zebrafish is a predictive model for identifying compounds that protect against brain toxicity in severe acute organophosphorus intoxication.
Journal: Archives of toxicology 20170101
Title: Design and synthesis of N-substituted-2-hydroxyiminoacetamides and interactions with cholinesterases.
Journal: Chemico-biological interactions 20161125
Title: Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease.
Journal: European journal of medicinal chemistry 20160127
Title: Zebrafish biosensor for toxicant induced muscle hyperactivity.
Journal: Scientific reports 20160101
Title: Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
Journal: Neuroscience 20150709
Title: Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
Journal: Toxicology letters 20150203
Title: Cloning and characterization of a norbelladine 4'-O-methyltransferase involved in the biosynthesis of the Alzheimer's drug galanthamine in Narcissus sp. aff. pseudonarcissus.
Journal: PloS one 20140101
Title: Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors.
Journal: Chemico-biological interactions 20130325
Title: Cognitive enhancement as a treatment for drug addictions.
Journal: Neuropharmacology 20130101
Title: Simultaneous quantification of Amaryllidaceae alkaloids from Zephyranthes grandiflora by UPLC-DAD/ESI-MS/MS.
Journal: Journal of pharmaceutical and biomedical analysis 20121201
Title: Design, synthesis, and bioevaluation of benzamides: novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Aβ aggregation, and β-secretase.
Journal: Bioorganic & medicinal chemistry 20121115
Title: Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B.
Journal: Journal of medicinal chemistry 20121108
Title: Food-drug interactions: effect of capsaicin on the pharmacokinetics of galantamine in rats.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20121101
Title: In-vitro evaluation of the P-glycoprotein interactions of a series of potentially CNS-active Amaryllidaceae alkaloids.
Journal: The Journal of pharmacy and pharmacology 20121101
Title: Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system.
Journal: International journal of pharmaceutics 20121015
Title: A novel class of selective acetylcholinesterase inhibitors: synthesis and evaluation of (E)-2-(benzo[d]thiazol-2-yl)-3-heteroarylacrylonitriles.
Journal: Molecules (Basel, Switzerland) 20121015
Title: The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions.
Journal: Pharmacology, biochemistry, and behavior 20121001
Title: Quantification of galantamine in human plasma by validated liquid chromatography-tandem mass spectrometry using glimepride as an internal standard: application to bioavailability studies in 32 healthy Korean subjects.
Journal: Journal of chromatographic science 20121001
Title: Apoptosis-inducing effects of distichamine and narciprimine, rare alkaloids of the plant family Amaryllidaceae.
Journal: Bioorganic & medicinal chemistry letters 20121001
Title: Mapping of the interaction sites of galanthamine: a quantitative analysis through pairwise potentials and quantum chemistry.
Journal: Journal of computer-aided molecular design 20121001
Title: Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120901
Title: Effects of fungicides on galanthamine and metabolite profiles in Narcissus bulbs.
Journal: Plant physiology and biochemistry : PPB 20120901
Title: High-performance liquid chromatography with fast-scanning fluorescence detection and multivariate curve resolution for the efficient determination of galantamine and its main metabolites in serum.
Journal: Analytica chimica acta 20120831
Title: Pharmacological properties and protein binding capacity of phenolic extracts of some Venda medicinal plants used against cough and fever.
Journal: Journal of ethnopharmacology 20120830
Title: Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking.
Journal: Molecules (Basel, Switzerland) 20120824
Title: Effect on cognition of galanthamine administered for neuromuscular block reversal in octogenarians undergoing cataract surgery.
Journal: Anaesthesiology intensive therapy 20120808
Title: Production of galanthamine by Leucojum aestivum shoots grown in different bioreactor systems.
Journal: Applied biochemistry and biotechnology 20120801
Title: Acetylcholinesterase inhibitors: a patent review (2008 - present).
Journal: Expert opinion on therapeutic patents 20120801
Title: Gingko biloba extract EGb 761®: clinical data in dementia.
Journal: International psychogeriatrics 20120801
Title: GC-MS of amaryllidaceous galanthamine-type alkaloids.
Journal: Journal of mass spectrometry : JMS 20120801
Title: Effects of single treatment of anti-dementia drugs on sleep-wake patterns in rats.
Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 20120801
Title: Clinical practice with antidementia drugs in a geriatric clinic.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120801
Title: Geranylphenazinediol, an acetylcholinesterase inhibitor produced by a Streptomyces species.
Journal: Journal of natural products 20120727
Title: Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template.
Journal: Bioorganic & medicinal chemistry letters 20120715
Title: Two galantamine titration regimens in patients switched from donepezil.
Journal: Acta neurologica Scandinavica 20120701
Title: The acetylcholinesterase inhibitors competitively inhibited an acetyl L-carnitine transport through the blood-brain barrier.
Journal: Neurochemical research 20120701
Title: 8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid and its diastereomers improve age-related cognitive deterioration.
Journal: Lipids 20120701
Title: Galantamine administration in chronic post-stroke aphasia.
Journal: Journal of neurology, neurosurgery, and psychiatry 20120701
Title: Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents.
Journal: Bioorganic & medicinal chemistry letters 20120701
Title: Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids.
Journal: Natural product communications 20120701
Title: Galantamine effect on tularemia pathogenesis in a BALB/c mouse model.
Journal: Iranian biomedical journal 20120701
Title: Steroidal alkaloids from Holarrhena antidysenterica as acetylcholinesterase inhibitors and the investigation for structure-activity relationships.
Journal: Life sciences 20120614
Title: Tacrine-silibinin codrug shows neuro- and hepatoprotective effects in vitro and pro-cognitive and hepatoprotective effects in vivo.
Journal: Journal of medicinal chemistry 20120614
Title: Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study.
Journal: European archives of psychiatry and clinical neuroscience 20120601
Title: Assessing health-related quality-of-life changes in informal caregivers: an evaluation in parents of children with major congenital anomalies.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20120601
Title: Galantamine-based hybrid molecules with acetylcholinesterase, butyrylcholinesterase and γ-secretase inhibition activities.
Journal: Current Alzheimer research 20120601
Title: Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats.
Journal: Neuropharmacology 20120601
Title: From pathophysiological aspects towards unravelling the neurobiological background of cognitive deficits.
Journal: European archives of psychiatry and clinical neuroscience 20120601
Title: Total synthesis of (-)-galanthamine and (-)-lycoramine via catalytic asymmetric hydrogenation and intramolecular reductive Heck cyclization.
Journal: Organic letters 20120601
Title: Alzheimer's disease: early diagnosis and treatment.
Journal: Hong Kong medical journal = Xianggang yi xue za zhi 20120601
Title: Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study.
Journal: Psychiatry investigation 20120601
Title: ESI-MS/MS stability-indicating bioanalytical method development and validation for simultaneous estimation of donepezil, 5-desmethyl donepezil and 6-desmethyl donepezil in human plasma.
Journal: Biomedical chromatography : BMC 20120501
Title: The novel object recognition memory: neurobiology, test procedure, and its modifications.
Journal: Cognitive processing 20120501
Title: Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity--application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive control.
Journal: European journal of clinical pharmacology 20120501
Title: Design, synthesis and evaluation of novel 16-imidazolyl substituted steroidal derivatives possessing potent diversified pharmacological properties.
Journal: Steroids 20120501
Title: Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC-MS to UPLC-MS/MS.
Journal: Journal of pharmaceutical and biomedical analysis 20120501
Title: Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease?
Journal: American journal of Alzheimer's disease and other dementias 20120501
Title: Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses.
Journal: Drugs 20120416
Title: Galantamine (Reminyl) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current.
Journal: European journal of pharmacology 20120415
Title: Prospective acetylcholinesterase inhibitory activity of indole and its analogs.
Journal: Bioorganic & medicinal chemistry letters 20120415
Title: Combination of chronic stress and ovariectomy causes conditioned fear memory deficits and hippocampal cholinergic neuronal loss in mice.
Journal: Neuroscience 20120405
Title: New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.
Journal: British journal of clinical pharmacology 20120401
Title: Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.
Journal: Psychopharmacology 20120401
Title: Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors.
Journal: Pharmacology & therapeutics 20120401
Title: Drugs for Alzheimer's disease.
Journal: British journal of clinical pharmacology 20120401
Title: Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression.
Journal: The Annals of pharmacotherapy 20120401
Title: Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.
Journal: Molecular psychiatry 20120301
Title: Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.
Journal: Cold Spring Harbor perspectives in medicine 20120301
Title: Investigation of anticholinergic and non-steroidal anti-inflammatory prodrugs which reduce chemically induced skin inflammation.
Journal: Journal of applied toxicology : JAT 20120201
Title: Cholinesterases inhibitory and antioxidant activities of Harpagophytum procumbens from in vitro systems.
Journal: Phytotherapy research : PTR 20120201
Title: Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation.
Journal: Neuropharmacology 20120201
Title: Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer.
Journal: PLoS computational biology 20120201
Title: Stem cells in drug screening for neurodegenerative disease.
Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 20120201
Title: [Pharmacological profiles of galantamine: the involvement of muscarinic receptor].
Journal: Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20120201
Title: Acetylcholinesterase inhibitors for schizophrenia.
Journal: The Cochrane database of systematic reviews 20120118
Title: Alkaloid patterns in Leucojum aestivum shoot culture cultivated at temporary immersion conditions.
Journal: Journal of plant physiology 20120115
Title: Histamine reverses a memory deficit induced in rats by early postnatal maternal deprivation.
Journal: Neurobiology of learning and memory 20120101
Title: Broader considerations of higher doses of donepezil in the treatment of mild, moderate, and severe Alzheimer's disease.
Journal: International journal of Alzheimer's disease 20120101
Title: Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats.
Journal: Current Alzheimer research 20120101
Title: New acetylcholinesterase inhibitors for Alzheimer's disease.
Journal: International journal of Alzheimer's disease 20120101
Title: A searchable cross-platform gene expression database reveals connections between drug treatments and disease.
Journal: BMC genomics 20120101
Title: Systematic review on the efficacy and safety of herbal medicines for vascular dementia.
Journal: Evidence-based complementary and alternative medicine : eCAM 20120101
Title: A European study investigating patterns of transition from home care towards institutional dementia care: the protocol of a RightTimePlaceCare study.
Journal: BMC public health 20120101
Title: Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology.
Journal: Frontiers in pharmacology 20120101
Title: Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation.
Journal: BMC neurology 20120101
Title: Ethnobotanical treatment strategies against Alzheimer's disease.
Journal: Current Alzheimer research 20120101
Title: Evaluation of the effect of Ferula asafoetida Linn. gum extract on learning and memory in Wistar rats.
Journal: Indian journal of pharmacology 20120101
Title: Xirp proteins mark injured skeletal muscle in zebrafish.
Journal: PloS one 20120101
Title: Using the Guttman scale to define and estimate measurement error in items over time: the case of cognitive decline and the meaning of 'points lost'.
Journal: PloS one 20120101
Title: Metal chaperones: a holistic approach to the treatment of Alzheimer's disease.
Journal: Frontiers in psychiatry 20120101
Title: Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology.
Journal: International journal of molecular sciences 20120101
Title: Small molecule screening platform for assessment of cardiovascular toxicity on adult zebrafish heart.
Journal: BMC physiology 20120101
Title: Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors.
Journal: Journal of Alzheimer's disease : JAD 20120101
Title: Effect of toki-shakuyaku-san on regional cerebral blood flow in patients with mild cognitive impairment and Alzheimer's disease.
Journal: Evidence-based complementary and alternative medicine : eCAM 20120101
Title: A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand.
Journal: BMJ open 20120101
Title: β-Secretases, Alzheimer's Disease, and Down Syndrome.
Journal: Current gerontology and geriatrics research 20120101
Title: Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.
Journal: International journal of Alzheimer's disease 20120101
Title: Development of on-line high performance liquid chromatography (HPLC)-biochemical detection methods as tools in the identification of bioactives.
Journal: International journal of molecular sciences 20120101
Title: Centella asiatica Extract Improves Behavioral Deficits in a Mouse Model of Alzheimer's Disease: Investigation of a Possible Mechanism of Action.
Journal: International journal of Alzheimer's disease 20120101
Title: The economic impact of galantamine vs placebo: an analysis based on functional capacity in a Swedish cohort study.
Journal: Journal of medical economics 20120101
Title: RACK1 is a ribosome scaffold protein for β-actin mRNA/ZBP1 complex.
Journal: PloS one 20120101
Title: Alzheimer's disease: a clinical practice-oriented review.
Journal: Frontiers in neurology 20120101
Title: Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.
Journal: Frontiers in microbiology 20120101
Title: Novel therapeutics in Alzheimer's disease.
Journal: International journal of Alzheimer's disease 20120101
Title: Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress.
Journal: International journal of Alzheimer's disease 20120101
Title: The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Journal: Health technology assessment (Winchester, England) 20120101
Title: Age-related neurodegeneration and memory loss in down syndrome.
Journal: Current gerontology and geriatrics research 20120101
Title: [New anti-AD drugs--their possibilities and issues].
Journal: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20120101
Title: [Strategy and perspectives for development of Alzheimer disease-modifying drugs].
Journal: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20120101
Title: Behavioral and psychological symptoms of dementia.
Journal: Frontiers in neurology 20120101
Title: Donepezil combined with natural hirudin improves the clinical symptoms of patients with mild-to-moderate Alzheimer's disease: a 20-week open-label pilot study.
Journal: International journal of medical sciences 20120101
Title: A novel subject synchronization clinical trial design for Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD 20120101
Title: The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.
Journal: PloS one 20120101
Title: Use of cognitive enhancers for mild cognitive impairment: protocol for a systematic review and network meta-analysis.
Journal: Systematic reviews 20120101
Title: Treatment-resistant Schizophrenia: Evidence-based Strategies.
Journal: Mens sana monographs 20120101
Title: Increased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A(2A) Antagonist in Cocaine Dependent Subjects.
Journal: Frontiers in psychiatry 20120101
Title: Cognitive dysfunction in multiple sclerosis.
Journal: Frontiers in neurology 20120101
Title: A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.
Journal: The journal of nutrition, health & aging 20120101
Title: Neuroprotective Activity of Sibjeondaebo-tang on Aβ Peptide-Induced Damages.
Journal: Evidence-based complementary and alternative medicine : eCAM 20120101
Title: Intranasal 'painless' human Nerve Growth Factor [corrected] slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice.
Journal: PloS one 20120101
Title: Wading pools, fading memories-place navigation in transgenic mouse models of Alzheimer's disease.
Journal: Frontiers in aging neuroscience 20120101
Title: Bipolar disorder: clinical perspectives and implications with cognitive dysfunction and dementia.
Journal: Depression research and treatment 20120101
Title: Controlled release reservoir mini tablets approach for controlling the drug release of Galantamine Hydrobromide.
Journal: Pharmaceutical development and technology 20120101
Title: Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects.
Journal: Oxidative medicine and cellular longevity 20120101
Title: Efficacy of cognitive enhancers for Alzheimer's disease: protocol for a systematic review and network meta-analysis.
Journal: Systematic reviews 20120101
Title: Transdermal donepezil on the treatment of Alzheimer's disease.
Journal: Neuropsychiatric disease and treatment 20120101
Title: Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Journal: Journal of medicinal chemistry 20111222
Title: Polymorphic microsatellite loci for the genetic analysis of Lycoris radiata (Amaryllidaceae) and cross-amplification in other congeneric species.
Journal: Genetics and molecular research : GMR 20111219
Title: Role of cholinergic markers on memory function of rats exposed to hypobaric hypoxia.
Journal: European journal of pharmacology 20111215
Title: Donepezil, but not galantamine, blocks muscarinic receptor-mediated in vitro and in vivo responses.
Journal: Synapse (New York, N.Y.) 20111201
Title: Galantamine counteracts development of learning impairment in guinea pigs exposed to the organophosphorus poison soman: clinical significance.
Journal: Neurotoxicology 20111201
Title: Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization.
Journal: Neuropharmacology 20111201
Title: Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus.
Journal: Neuropharmacology 20111201
Title: Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram.
Journal: Biochimica et biophysica acta 20111201
Title: The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory.
Journal: Neuroscience 20111201
Title: Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.
Journal: Bioorganic & medicinal chemistry 20111201
Title: Medicinal plants and dementia therapy: herbal hopes for brain aging?
Journal: CNS neuroscience & therapeutics 20111201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: Sundown syndrome in persons with dementia: an update.
Journal: Psychiatry investigation 20111201
Title: Isolation and cholinesterase activity of Amaryllidaceae alkaloids from Nerine bowdenii.
Journal: Natural product communications 20111201
Title: Alzheimer's dementia: current data review.
Journal: Collegium antropologicum 20111201
Title: The neurotrophins and their role in Alzheimer's disease.
Journal: Current neuropharmacology 20111201
Title: [Galantamine].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20111201
Title: Kinetic study of the rearrangement of deuterium-labeled 4'-O-methylnorbelladine in Leucojum aestivum shoot cultures by mass spectrometry. Influence of precursor feeding on amaryllidaceae alkaloid accumulation.
Journal: Journal of natural products 20111128
Title: Acetylcholinesterase-inhibiting alkaloids from Zephyranthes concolor.
Journal: Molecules (Basel, Switzerland) 20111115
Title: Galantamine and behavior in Alzheimer disease: analysis of four trials.
Journal: Acta neurologica Scandinavica 20111101
Title: BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.
Journal: European journal of clinical pharmacology 20111101
Title: Effects of galantamine in Alzheimer's disease: double-blind withdrawal studies evaluating sustained versus interrupted treatment.
Journal: Current Alzheimer research 20111101
Title: Symmetrical corticobasal syndrome caused by a novel C.314dup progranulin mutation.
Journal: Journal of molecular neuroscience : MN 20111101
Title: Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats.
Journal: Hormones and behavior 20111101
Title: Effective pharmacological management of Alzheimer's disease.
Journal: The American journal of managed care 20111101
Title: The costs of Alzheimer's disease and the value of effective therapies.
Journal: The American journal of managed care 20111101
Title: Galantamine rescues lead-impaired synaptic plasticity in rat dentate gyrus.
Journal: Toxicology 20111028
Title: Current and emerging drug treatment options for Alzheimer's disease: a systematic review.
Journal: Drugs 20111022
Title: Structural features and hydrogen-bond properties of galanthamine and codeine: an experimental and theoretical study.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany) 20111004
Title: Effects of a new synthetic butyrylcholinesterase inhibitor, HBU-39, on cell proliferation and neuroblast differentiation in the hippocampal dentate gyrus in a scopolamine-induced amnesia animal model.
Journal: Neurochemistry international 20111001
Title: Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.
Journal: CNS neuroscience & therapeutics 20111001
Title: Pharmacological treatment of Alzheimer disease.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie 20111001
Title: The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society 20111001
Title: Biological active compounds from Georgian Galanthus shaoricus.
Journal: Georgian medical news 20111001
Title: The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.
Journal: Behavioural brain research 20110930
Title: Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.
Journal: Toxicology letters 20110925
Title: 1,3-substituted imidazolidine-2,4,5-triones: synthesis and inhibition of cholinergic enzymes.
Journal: Molecules (Basel, Switzerland) 20110905
Title: Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation.
Journal: Hippocampus 20110901
Title: Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.
Journal: Pharmacology, biochemistry, and behavior 20110901
Title: Negative argument for debate with V. O. Emery for J Neural Transmission : Alzheimer's disease: are we intervening too late? No we are not. Con.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20110901
Title: An overview on natural cholinesterase inhibitors--a multi-targeted drug class--and their mass production.
Journal: Mini reviews in medicinal chemistry 20110901
Title: Primary progressive aphasias and their contribution to the contemporary knowledge about the brain-language relationship.
Journal: Neuropsychology review 20110901
Title: Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.
Journal: Expert opinion on investigational drugs 20110901
Title: Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20110901
Title: [Pharmacological and clinical profiles of galantamine (Reminyl(®))].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20110901
Title: Efficacy and safety of switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch in patients with probable Alzheimer's disease.
Journal: Journal of clinical neurology (Seoul, Korea) 20110901
Title: Asymmetric synthesis of bioactive hydrodibenzofuran alkaloids: (-)-lycoramine, (-)-galanthamine, and (+)-lunarine.
Journal: Angewandte Chemie (International ed. in English) 20110822
Title: Alkaloids from Hippeastrum papilio.
Journal: Molecules (Basel, Switzerland) 20110818
Title: Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.
Journal: Journal of psychopharmacology (Oxford, England) 20110801
Title: A new test of the construct validity of the CarerQol instrument: measuring the impact of informal care giving.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20110801
Title: Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors.
Journal: Bioorganic chemistry 20110801
Title: Cytochrome P450 2D6 phenotyping in an elderly population with dementia and response to galantamine in dementia: a pilot study.
Journal: The American journal of geriatric pharmacotherapy 20110801
Title: [Newly approved drugs for Alzheimer disease: effectiveness and limitation].
Journal: Brain and nerve = Shinkei kenkyu no shinpo 20110801
Title: New drugs for Alzheimer's disease in Japan.
Journal: Psychiatry and clinical neurosciences 20110801
Title: Acetylcholinesterase inhibition by somes promising Brazilian medicinal plants.
Journal: Brazilian journal of biology = Revista brasleira de biologia 20110801
Title: Vascular dementia.
Journal: Chonnam medical journal 20110801
Title: Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: a study in a real life population.
Journal: Geriatrics & gerontology international 20110701
Title: [Daily functioning in dementia: pharmacological and non-pharmacological interventions demonstrate small effects on heterogeneous scales].
Journal: Psychiatrische Praxis 20110701
Title: [Prescription differences of dementia drugs in urban and rural areas in Germany].
Journal: Psychiatrische Praxis 20110701
Title: Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa.
Journal: European journal of medicinal chemistry 20110701
Title: Combination therapy for Alzheimer's disease.
Journal: Drugs & aging 20110701
Title: Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
Journal: The international journal of neuropsychopharmacology 20110601
Title: VAChT knock-down mice show normal prepulse inhibition but disrupted long-term habituation.
Journal: Genes, brain, and behavior 20110601
Title: In vitro antioxidant, anticholinesterase and antimicrobial activity studies on three Agaricus species with fatty acid compositions and iron contents: a comparative study on the three most edible mushrooms.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20110601
Title: N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
Journal: European journal of medicinal chemistry 20110601
Title: Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Journal: European journal of medicinal chemistry 20110601
Title: The role of phytochemicals in the treatment and prevention of dementia.
Journal: Drugs & aging 20110601
Title: Design, synthesis and biological evaluation of new 2-benzoxazolinone derivatives as potential cholinesterase inhibitors for therapy of alzheimer's disease.
Journal: Die Pharmazie 20110601
Title: In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity.
Journal: Future medicinal chemistry 20110601
Title: Galantamine potentiates the protective effect of rofecoxib and caffeic acid against intrahippocampal Kainic acid-induced cognitive dysfunction in rat.
Journal: Brain research bulletin 20110530
Title: Possible role of cholinesterase inhibitors on memory consolidation following hypobaric hypoxia of rats.
Journal: The International journal of neuroscience 20110501
Title: Drug delivery strategies for Alzheimer's disease treatment.
Journal: Expert opinion on drug delivery 20110501
Title: Effects of galantamine on cocaine use in chronic cocaine users.
Journal: The American journal on addictions 20110501
Title: Alternative drug therapies for dementia.
Journal: Journal of psychosocial nursing and mental health services 20110501
Title: Analgesic and antineuropathic drugs acting through central cholinergic mechanisms.
Journal: Recent patents on CNS drug discovery 20110501
Title: In Salvia miltiorrhiza, phenolic acids possess protective properties against amyloid β-induced cytotoxicity, and tanshinones act as acetylcholinesterase inhibitors.
Journal: Environmental toxicology and pharmacology 20110501
Title: Stability-indicating study of the anti-Alzheimer's drug galantamine hydrobromide.
Journal: Journal of pharmaceutical and biomedical analysis 20110428
Title: Effect of fertilizers on galanthamine and metabolite profiles in Narcissus bulbs by 1H NMR.
Journal: Journal of agricultural and food chemistry 20110413
Title: Antioxidant and anticholinesterase constituents from the petroleum ether and chloroform extracts of Iris suaveolens.
Journal: Phytotherapy research : PTR 20110401
Title: Switching cholinesterase inhibitors in older adults with dementia.
Journal: International psychogeriatrics 20110401
Title: Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.
Journal: Journal of proteome research 20110401
Title: Synthesis of (-)-homogalanthamine from naltrexone.
Journal: The Journal of organic chemistry 20110401
Title: Simultaneous determination of antidementia drugs in human plasma for therapeutic drug monitoring.
Journal: Therapeutic drug monitoring 20110401
Title: Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.
Journal: Bioorganic & medicinal chemistry 20110401
Title: Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors.
Journal: Bioorganic & medicinal chemistry 20110401
Title: Newer molecules in the treatment of schizophrenia: A clinical update.
Journal: Indian journal of pharmacology 20110401
Title: Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome.
Journal: American journal of medical genetics. Part A 20110401
Title: Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
Journal: Prescrire international 20110401
Title: Physical activity attenuates neuropsychiatric disturbances and caregiver burden in patients with dementia.
Journal: Clinics (Sao Paulo, Brazil) 20110401
Title: Prescribing trends in cognition enhancing drugs in Australia.
Journal: International psychogeriatrics 20110301
Title: Treatment efficacy in a soman-poisoned guinea pig model: added value of physostigmine?
Journal: Archives of toxicology 20110301
Title: Molecular cloning and characterization of a phenylalanine ammonia-lyase gene (LrPAL) from Lycoris radiata.
Journal: Molecular biology reports 20110301
Title: Advances in mass spectrometry-based post-column bioaffinity profiling of mixtures.
Journal: Analytical and bioanalytical chemistry 20110301
Title: Synapse- and subtype-specific modulation of synaptic transmission by nicotinic acetylcholine receptors in the ventrobasal thalamus.
Journal: Neuroscience research 20110301
Title: Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110301
Title: Long-term response to galantamine in relation to short-term efficacy data: pooled analysis in patients with mild to moderate Alzheimer's disease.
Journal: Current Alzheimer research 20110301
Title: Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20110301
Title: Cardio-vascular safety of acetyl cholinesterase inhibitors in patients suffering from Alzheimer's disease; factors that predict poor tolerability.
Journal: International journal of geriatric psychiatry 20110301
Title: Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy.
Journal: CNS drugs 20110301
Title: Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
Journal: The neurologist 20110301
Title: Antioxidant activity of a Mediterranean food product: 'fig syrup'.
Journal: Nutrients 20110301
Title: Development and validation of a GC-MS method for rapid determination of galanthamine in Leucojum aestivum and Narcissus ssp.: a metabolomic approach.
Journal: Talanta 20110215
Title: Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
Journal: The Gerontologist 20110201
Title: Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia.
Journal: Schizophrenia research 20110201
Title: Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method.
Journal: Nanomedicine : nanotechnology, biology, and medicine 20110201
Title: Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation.
Journal: British journal of pharmacology 20110201
Title: Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats.
Journal: Behavioural pharmacology 20110201
Title: Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors.
Journal: Bioorganic & medicinal chemistry 20110201
Title: Safety and tolerability of galantamine SA in dementia patients transitioned from donepezil.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110201
Title: Psychotropic medication use among elderly nursing home residents in Slovenia: cross-sectional study.
Journal: Croatian medical journal 20110201
Title: Galantamine improves sustained attention in chronic cocaine users.
Journal: Experimental and clinical psychopharmacology 20110201
Title: Biotransformation of turmerones by Aspergillus niger.
Journal: Journal of natural products 20110128
Title: Ion mobility spectrometry: a valuable tool for kinetic studies in enzymology.
Journal: Analytica chimica acta 20110124
Title: A systematic review of single chinese herbs for Alzheimer's disease treatment.
Journal: Evidence-based complementary and alternative medicine : eCAM 20110101
Title: Protective Effects of Rosa damascena and Its Active Constituent on Aβ(25-35)-Induced Neuritic Atrophy.
Journal: Evidence-based complementary and alternative medicine : eCAM 20110101
Title: Galanthamine and related alkaloids production by Leucojum aestivum L. shoot culture using a temporary immersion technology.
Journal: Applied biochemistry and biotechnology 20110101
Title: Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment.
Journal: Alzheimer disease and associated disorders 20110101
Title: Respiratory myoclonus, a side effect of galantamine.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101
Title: Silanetriols as in vitro inhibitors for AChE.
Journal: Bioorganic & medicinal chemistry letters 20110101
Title: Cognitive enhancement by drugs in health and disease.
Journal: Trends in cognitive sciences 20110101
Title: Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients.
Journal: Journal of Alzheimer's disease : JAD 20110101
Title: The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies.
Journal: Journal of biomedical science 20110101
Title: Protective effect of curcumin (Curcuma longa) against D-galactose-induced senescence in mice.
Journal: Journal of Asian natural products research 20110101
Title: Alkaloid diversity in Galanthus elwesii and Galanthus nivalis.
Journal: Chemistry & biodiversity 20110101
Title: Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology.
Journal: BMC neurology 20110101
Title: Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases.
Journal: Journal of Alzheimer's disease : JAD 20110101
Title: Cognitive-enhancing effects of polygalasaponin hydrolysate in aβ(25-35)-induced amnesic mice.
Journal: Evidence-based complementary and alternative medicine : eCAM 20110101
Title: Rehabilitating a brain with Alzheimer's: a proposal.
Journal: Clinical interventions in aging 20110101
Title: Association between prescription of conventional or atypical antipsychotic drugs and mortality in older persons with Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders 20110101
Title: Pharmacological aspects of the acetylcholinesterase inhibitor galantamine.
Journal: Journal of pharmacological sciences 20110101
Title: Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
Journal: Alzheimer's research & therapy 20110101
Title: [Cholinesterase blockers in anesthesiology: a replenishment of former arsenal].
Journal: Anesteziologiia i reanimatologiia 20110101
Title: Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia.
Journal: Chinese medicine 20110101
Title: Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
Journal: Neuropsychiatric disease and treatment 20110101
Title: Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial.
Journal: Journal of Alzheimer's disease : JAD 20110101
Title: Bacopa monniera Attenuates Scopolamine-Induced Impairment of Spatial Memory in Mice.
Journal: Evidence-based complementary and alternative medicine : eCAM 20110101
Title: Chronic fatigue syndrome.
Journal: BMJ clinical evidence 20110101
Title: Age sensitivity of behavioral tests and brain substrates of normal aging in mice.
Journal: Frontiers in aging neuroscience 20110101
Title: Clinical features and multidisciplinary approaches to dementia care.
Journal: Journal of multidisciplinary healthcare 20110101
Title: Neuroprotective effects of marine algae.
Journal: Marine drugs 20110101
Title: Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease.
Journal: Alzheimer's research & therapy 20110101
Title: Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease.
Journal: Alzheimer's research & therapy 20110101
Title: The 'aged garlic extract:' (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD).
Journal: Current medicinal chemistry 20110101
Title: Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice.
Journal: Molecular medicine (Cambridge, Mass.) 20110101
Title: Donepezil, anti-Alzheimer's disease drug, prevents cardiac rupture during acute phase of myocardial infarction in mice.
Journal: PloS one 20110101
Title: Transcranial magnetic stimulation studies in Alzheimer's disease.
Journal: International journal of Alzheimer's disease 20110101
Title: Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.
Journal: Frontiers in systems neuroscience 20110101
Title: Predictors of long-term cognitive outcome in Alzheimer's disease.
Journal: Alzheimer's research & therapy 20110101
Title: Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia.
Journal: Neuropsychiatric disease and treatment 20110101
Title: Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons.
Journal: PloS one 20110101
Title: Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands.
Journal: Neuropsychiatric disease and treatment 20110101
Title: Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians.
Journal: BMC neurology 20110101
Title: Age-related white matter changes.
Journal: Journal of aging research 20110101
Title: Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective study.
Journal: Journal of Alzheimer's disease : JAD 20110101
Title: Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkers.
Journal: PloS one 20110101
Title: Examining brain-cognition effects of ginkgo biloba extract: brain activation in the left temporal and left prefrontal cortex in an object working memory task.
Journal: Evidence-based complementary and alternative medicine : eCAM 20110101
Title: Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706.
Journal: Frontiers in molecular neuroscience 20110101
Title: Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-Amyloid.
Journal: Frontiers in molecular neuroscience 20110101
Title: Quality of online pharmacies and websites selling prescription drugs: a systematic review.
Journal: Journal of medical Internet research 20110101
Title: Meningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood-brain barrier are modulated by alpha7 nicotinic receptor.
Journal: PloS one 20110101
Title: Market Access Agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts.
Journal: BMC health services research 20110101
Title: Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment.
Journal: Alzheimer's research & therapy 20110101
Title: Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.
Journal: Neuropsychiatric disease and treatment 20110101
Title: Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital.
Journal: Indian journal of psychological medicine 20110101
Title: [Sleep disorders in patients with dementia in Parkinson's disease].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101
Title: Biomarkers to measure treatment effects in Alzheimer's disease: what should we look for?
Journal: International journal of Alzheimer's disease 20110101
Title: Impact of early intervention and disease modification in patients with predementia Alzheimer's disease: a Markov model simulation.
Journal: ClinicoEconomics and outcomes research : CEOR 20110101
Title: Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats.
Journal: PloS one 20110101
Title: State-of-the-Art Automated Patch Clamp Devices: Heat Activation, Action Potentials, and High Throughput in Ion Channel Screening.
Journal: Frontiers in pharmacology 20110101
Title: Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development.
Journal: Alzheimer's research & therapy 20110101
Title: Targeting acetylcholinesterase: identification of chemical leads by high throughput screening, structure determination and molecular modeling.
Journal: PloS one 20110101
Title: Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.
Journal: BMC psychiatry 20110101
Title: Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease.
Journal: Alzheimer's research & therapy 20110101
Title: Amnestic mild cognitive impairment and early Alzheimer's disease in an asian memory clinic - evidence for a clinical spectrum.
Journal: Dementia and geriatric cognitive disorders extra 20110101
Title: A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders extra 20110101
Title: The efficacy of licensed-indication use of donepezil and memantine monotherapies for treating behavioural and psychological symptoms of dementia in patients with Alzheimer's disease: systematic review and meta-analysis.
Journal: Dementia and geriatric cognitive disorders extra 20110101
Title: [The application of multichannel electrostimulation and nivalin electrophoresis for the rehabilitative treatment of the patient following plastic surgery in the facial region].
Journal: Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 20110101
Title: Huperzine induces alteration in oxidative balance and antioxidants in a guinea pig model.
Journal: Neuro endocrinology letters 20110101
Title: A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease.
Journal: PloS one 20110101
Title: Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease).
Journal: Journal of drug delivery 20110101
Title: Transcriptional response of zebrafish embryos exposed to neurotoxic compounds reveals a muscle activity dependent hspb11 expression.
Journal: PloS one 20110101
Title: ENU mutagenesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice.
Journal: Journal of biomedicine & biotechnology 20110101
Title: Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy.
Journal: Biochemistry research international 20110101
Title: Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome.
Journal: Scientific reports 20110101
Title: [The application of electrical stimulation by bipolar pulsed currents and galanthamine electrophoresis for the rehabilitation of patients with diabetes mellitus].
Journal: Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 20110101
Title: Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors.
Journal: The Journal of biological chemistry 20101217
Title: Alkaloids from stems of Esenbeckia leiocarpa Engl. (Rutaceae) as potential treatment for Alzheimer disease.
Journal: Molecules (Basel, Switzerland) 20101213
Title: Structural insights to investigate Conypododiol as a dual cholinesterase inhibitor from Asparagus adscendens.
Journal: Fitoterapia 20101201
Title: Identification of non-alkaloid acetylcholinesterase inhibitors from Ferulago campestris (Besser) Grecescu (Apiaceae).
Journal: Fitoterapia 20101201
Title: Localization by site-directed mutagenesis of a galantamine binding site on α7 nicotinic acetylcholine receptor extracellular domain.
Journal: Journal of receptor and signal transduction research 20101201
Title: Frontotemporal dementia: a review for primary care physicians.
Journal: American family physician 20101201
Title: Alzheimer's disease: aging, insomnia and epigenetics.
Journal: Taiwanese journal of obstetrics & gynecology 20101201
Title: Vascular cognitive impairment: Current concepts and Indian perspective.
Journal: Annals of Indian Academy of Neurology 20101201
Title: Triterpenoidal alkaloids from Buxus natalensis and their acetylcholinesterase inhibitory activity.
Journal: Journal of natural products 20101129
Title: Citrusosides A-D and furanocoumarins with cholinesterase inhibitory activity from the fruit peels of Citrus hystrix.
Journal: Journal of natural products 20101129
Title: Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems.
Journal: The international journal of neuropsychopharmacology 20101101
Title: Effects of galantamine on β-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells.
Journal: Experimental gerontology 20101101
Title: Protective effects of galantamine against Abeta-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress.
Journal: Neurochemistry international 20101101
Title: Indole alkaloids from Ervatamia hainanensis with potent acetylcholinesterase inhibition activities.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease.
Journal: CNS drugs 20101101
Title: Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease.
Journal: Documenta ophthalmologica. Advances in ophthalmology 20101001
Title: Regulation of peripheral inflammation by the central nervous system.
Journal: Current rheumatology reports 20101001
Title: [Beneficial effect of galantamine on sensory information-processing deficits].
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20101001
Title: Effects of cholinergic agonists and antagonists under conditions of spleen denervation in rats with endotoxic shock.
Journal: Bulletin of experimental biology and medicine 20101001
Title: Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
Journal: The American journal of geriatric pharmacotherapy 20101001
Title: Adult neurogenesis and neural stem cells as a model for the discovery and development of novel drugs.
Journal: Expert opinion on drug discovery 20101001
Title: Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.
Journal: Neuroscience 20100915
Title: Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro.
Journal: Chemico-biological interactions 20100906
Title: Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association 20100901
Title: Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells.
Journal: Journal of pineal research 20100901
Title: Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus.
Journal: The Journal of pharmacology and experimental therapeutics 20100901
Title: Structure-activity studies on acetylcholinesterase inhibition in the lycorine series of Amaryllidaceae alkaloids.
Journal: Bioorganic & medicinal chemistry letters 20100901
Title: Current treatments for patients with Alzheimer disease.
Journal: The Journal of the American Osteopathic Association 20100901
Title: [Treatment of Alzheimer's disease: the current situation?].
Journal: Revue medicale de Bruxelles 20100901
Title: Galantamine inhibits calpain-calcineurin signaling activated by beta-amyloid in human neuroblastoma SH-SY5Y cells.
Journal: Neuroscience letters 20100823
Title: Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles.
Journal: Bioorganic & medicinal chemistry 20100815
Title: Predictors of adherence among Alzheimer's disease patients receiving oral therapy.
Journal: Current medical research and opinion 20100801
Title: Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.
Journal: Drugs & aging 20100801
Title: Determination of galanthamine in Bulbus Lycoridis Radiatae by coupling capillary electrophoresis with end-column electrochemiluminescence detection.
Journal: Journal of separation science 20100801
Title: Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives.
Journal: Journal of medicinal chemistry 20100722
Title: Morphinans and isoquinolines: acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors.
Journal: Bioorganic & medicinal chemistry 20100715
Title: Effect of isoquinoline alkaloids from two Hippeastrum species on in vitro acetylcholinesterase activity.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20100701
Title: [S3 guidelines on dementia. Symptomatic therapy of dementia].
Journal: Der Nervenarzt 20100701
Title: [Development of new drugs for Alzheimer's disease].
Journal: Brain and nerve = Shinkei kenkyu no shinpo 20100701
Title: Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharide-induced peritonitis.
Journal: Chinese medical journal 20100701
Title: Spectrofluorimetry in organized media coupled to second-order multivariate calibration for the determination of galantamine in the presence of uncalibrated interferences.
Journal: Talanta 20100630
Title: Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
Journal: Bioorganic & medicinal chemistry 20100615
Title: Young and older good learners have higher levels of brain nicotinic receptor binding.
Journal: Neurobiology of aging 20100601
Title: Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review.
Journal: Pharmacological research 20100601
Title: Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism.
Journal: The Journal of pharmacology and experimental therapeutics 20100601
Title: Entering and exiting the Medicare part D coverage gap: role of comorbidities and demographics.
Journal: Journal of general internal medicine 20100601
Title: Cholinesterase inhibitors ameliorate spatial learning deficits in rats following hypobaric hypoxia.
Journal: Experimental brain research 20100601
Title: [Acetylcholinesterase inhibitors in Alzheimer's disease: further comments on their mechanisms of action and therapeutic consequences].
Journal: Psychologie & neuropsychiatrie du vieillissement 20100601
Title: The dramatic effects of Galantamine in a patient with early-onset Alzheimer's disease.
Journal: Psychiatria Danubina 20100601
Title: [Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands].
Journal: Tijdschrift voor gerontologie en geriatrie 20100601
Title: Antiamnesic effect of stevioside in scopolamine-treated rats.
Journal: Indian journal of pharmacology 20100601
Title: Semisynthesis and acetylcholinesterase inhibitory activity of stemofoline alkaloids and analogues.
Journal: Journal of natural products 20100528
Title: Galantamine inhibits slowly inactivating K+ currents with a dual dose-response relationship in differentiated N1E-115 cells and in CA1 neurones.
Journal: European journal of pharmacology 20100525
Title: Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.
Journal: Journal of medicinal chemistry 20100513
Title: Total synthesis of (+/-)-galanthamine via a C3-selective Stille coupling and IMDA cycloaddition cascade of 3,5-dibromo-2-pyrone.
Journal: Organic letters 20100507
Title: A review of clinical pharmacokinetics and pharmacodynamics of galantamine, a reversible acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, in healthy subjects and patients.
Journal: Current clinical pharmacology 20100501
Title: Behavioral side effects in rats treated with acetylcholinesterase inhibitors suggested used as prophylactics against nerve agents.
Journal: Pharmacology, biochemistry, and behavior 20100501
Title: Bivalent 5,8,9,13b-tetrahydro-6H-isoquino[1,2-a]isoquinolines and -isoquinolinium salts: novel heterocyclic templates for butyrylcholinesterase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20100501
Title: Anticholinesterase duration in the Australian veteran population.
Journal: The Australian and New Zealand journal of psychiatry 20100501
Title: Alternative method of oral dosing for rats.
Journal: Journal of the American Association for Laboratory Animal Science : JAALAS 20100501
Title: [Antianaphylactic effects of muscarinic antagonists].
Journal: Eksperimental'naia i klinicheskaia farmakologiia 20100501
Title: [Variability and trends in dementia drug consumption in Castile-La Mancha (Spain). Estimated prevalence of Alzheimer's disease].
Journal: Neurologia (Barcelona, Spain) 20100501
Title: In vitro biological activities of niloticane, a new bioactive cassane diterpene from the bark of Acacia nilotica subsp. kraussiana.
Journal: Journal of ethnopharmacology 20100421
Title: Super-short solid silicon microneedles for transdermal drug delivery applications.
Journal: International journal of pharmaceutics 20100415
Title: Acetylcholinesterase inhibitory potential of a carbazole alkaloid, mahanimbine, from Murraya koenigii.
Journal: Phytotherapy research : PTR 20100401
Title: Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature.
Journal: CNS drugs 20100401
Title: [Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis].
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20100401
Title: Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions.
Journal: British journal of clinical pharmacology 20100401
Title: Calcium signaling and neurodegeneration.
Journal: Acta naturae 20100401
Title: S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies.
Journal: Biological psychiatry 20100315
Title: Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus.
Journal: Bioorganic & medicinal chemistry 20100315
Title: Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20100301
Title: Prescribing of drugs for Alzheimer's disease: a South African database analysis.
Journal: International psychogeriatrics 20100301
Title: Galantamine for Alzheimer's disease.
Journal: Expert opinion on drug metabolism & toxicology 20100301
Title: Reversible acetylcholinesterase inhibitory effect of Tabernaemontana divaricata extract on synaptic transmission in rat CA1 hippocampus.
Journal: The Indian journal of medical research 20100301
Title: Update on the pharmacological treatment of Alzheimer's disease.
Journal: Current neuropharmacology 20100301
Title: The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
Journal: International journal of geriatric psychiatry 20100201
Title: Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors.
Journal: International psychogeriatrics 20100201
Title: Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20100201
Title: [A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?].
Journal: Journal des maladies vasculaires 20100201
Title: Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
Journal: Bioorganic & medicinal chemistry 20100201
Title: Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.
Journal: CNS drugs 20100201
Title: Acetylcholinesterases of the cat flea Ctenocephalides felis: identification of two distinct genes and biochemical characterization of recombinant and in vivo enzyme activities.
Journal: Insect biochemistry and molecular biology 20100201
Title: Iron leads to memory impairment that is associated with a decrease in acetylcholinesterase pathways.
Journal: Current neurovascular research 20100201
Title: Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies.
Journal: Current Alzheimer research 20100201
Title: Galantamine does not cause aggravated orthostatic hypotension in people with Alzheimer's disease.
Journal: Journal of the American Geriatrics Society 20100201
Title: Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors.
Journal: Cell death & disease 20100201
Title: Probing Torpedo californica acetylcholinesterase catalytic gorge with two novel bis-functional galanthamine derivatives.
Journal: Journal of medicinal chemistry 20100128
Title: Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy.
Journal: Journal of molecular neuroscience : MN 20100101
Title: The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
Journal: Journal of molecular neuroscience : MN 20100101
Title: Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning.
Journal: Journal of molecular neuroscience : MN 20100101
Title: Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection.
Journal: Journal of molecular neuroscience : MN 20100101
Title: Analysis of metabolic variation and galanthamine content in Narcissus bulbs by 1H NMR.
Journal: Phytochemical analysis : PCA 20100101
Title: Metabolic profiling of bioactive Pancratium canariense extracts by GC-MS.
Journal: Phytochemical analysis : PCA 20100101
Title: Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman.
Journal: Neurotoxicology 20100101
Title: Promotion effect of norgalanthamine, a component of Crinum asiaticum, on hair growth.
Journal: European journal of dermatology : EJD 20100101
Title: Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.
Journal: European journal of medicinal chemistry 20100101
Title: Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany.
Journal: International clinical psychopharmacology 20100101
Title: Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting.
Journal: CNS drugs 20100101
Title: New method for the study of Amaryllidaceae alkaloid biosynthesis using biotransformation of deuterium-labeled precursor in tissue cultures.
Journal: Acta biochimica Polonica 20100101
Title: Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch.
Journal: CNS neuroscience & therapeutics 20100101
Title: Cognitive enhancement as a pharmacotherapy target for stimulant addiction.
Journal: Addiction (Abingdon, England) 20100101
Title: Identification of inhibitors of Plasmodium falciparum phosphoethanolamine methyltransferase using an enzyme-coupled transmethylation assay.
Journal: BMC biochemistry 20100101
Title: Lycorine and its derivatives for anticancer drug design.
Journal: Mini reviews in medicinal chemistry 20100101
Title: Neurochemical basis for symptomatic treatment of Alzheimer's disease.
Journal: Neuropharmacology 20100101
Title: Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment.
Journal: BMC neurology 20100101
Title: Frontotemporal dementia and pharmacologic interventions.
Journal: The Journal of neuropsychiatry and clinical neurosciences 20100101
Title: Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease.
Journal: Clinical interventions in aging 20100101
Title: Cholinergic sensitivity of the developing bullfrog (Rana catesbeiana) does not explain vulnerability to chronic nicotine exposure.
Journal: Advances in experimental medicine and biology 20100101
Title: Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.
Journal: Molecular neurodegeneration 20100101
Title: Effects of Ginkgo biloba in dementia: systematic review and meta-analysis.
Journal: BMC geriatrics 20100101
Title: Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.
Journal: Dementia and geriatric cognitive disorders 20100101
Title: Important groups of alkaloids derived biosynthetically from phenylalanine and tyrosine. Preface.
Journal: The Alkaloids. Chemistry and biology 20100101
Title: Galanthamine from Galanthus and other Amaryllidaceae--chemistry and biology based on traditional use.
Journal: The Alkaloids. Chemistry and biology 20100101
Title: Galanthamine production by Leucojum aestivum cultures in vitro.
Journal: The Alkaloids. Chemistry and biology 20100101
Title: New prospectives in the delivery of galantamine for elderly patients using the IntelliDrug intraoral device: in vivo animal studies.
Journal: Current pharmaceutical design 20100101
Title: New lobane and cembrane diterpenes from two comorian soft corals.
Journal: Marine drugs 20100101
Title: Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?
Journal: Alzheimer's research & therapy 20100101
Title: In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of beta-amyloid plaques associated with Alzheimer's disease.
Journal: Theoretical biology & medical modelling 20100101
Title: Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use.
Journal: Journal of Alzheimer's disease : JAD 20100101
Title: Quantitative determination of Amaryllidaceae alkaloids from Galanthus reginae-olgae subsp. vernalis and in vitro activities relevant for neurodegenerative diseases.
Journal: Pharmaceutical biology 20100101
Title: Novel therapeutic drugs for neuropsychiatric disorders.
Journal: The open medicinal chemistry journal 20100101
Title: Compliance assessment of ambulatory Alzheimer patients to aid therapeutic decisions by healthcare professionals.
Journal: BMC health services research 20100101
Title: Changes in apolar metabolites during in vitro organogenesis of Pancratium maritimum.
Journal: Plant physiology and biochemistry : PPB 20100101
Title: Synthesis and antimicrobial, acetylcholinesterase and butyrylcholinesterase inhibitory activities of novel ester and hydrazide derivatives of 3(2H)-pyridazinone.
Journal: Arzneimittel-Forschung 20100101
Title: The Nuclear Receptor PPARgamma as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's Disease.
Journal: Frontiers in aging neuroscience 20100101
Title: Acetylcholinesterase inhibitory activity of uleine from Himatanthus lancifolius.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences 20100101
Title: Alkaloid accumulation in different parts and ages of Lycoris chinensis.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences 20100101
Title: [Anti-inflammatory role of cholinergic and serotonergic systems in shock].
Journal: Patologicheskaia fiziologiia i eksperimental'naia terapiia 20100101
Title: Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report.
Journal: BMC psychiatry 20100101
Title: Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literature.
Journal: BMC psychiatry 20100101
Title: Are guidelines needed for the diagnosis and management of incipient Alzheimer's disease and mild cognitive impairment?
Journal: International journal of Alzheimer's disease 20100101
Title: Circadian rhythm disturbances in patients with Alzheimer's disease: a review.
Journal: International journal of Alzheimer's disease 20100101
Title: Targeting S100B in Cerebral Ischemia and in Alzheimer's Disease.
Journal: Cardiovascular psychiatry and neurology 20100101
Title: Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment.
Journal: BMC neurology 20100101
Title: Galantamine in the treatment of minor depression with mild to moderate Alzheimer's dementia in an elderly woman.
Journal: Primary care companion to the Journal of clinical psychiatry 20100101
Title: A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease.
Journal: Alzheimer's research & therapy 20100101
Title: Modelling the clinical and economic implications of galantamine in the treatment of mild-to-moderate Alzheimer's disease in Germany.
Journal: Journal of medical economics 20100101
Title: Trace eyeblink conditioning is impaired in α7 but not in β2 nicotinic acetylcholine receptor knockout mice.
Journal: Frontiers in behavioral neuroscience 20100101
Title: Effect of elevated intra-abdominal pressure on the contractile activity and reactivity of smooth muscle tissue from rat gastrointestinal tract to galantamine and drotaverine (No-Spa).
Journal: Folia medica 20100101
Title: Effects of general practitioner training and family support services on the care of home-dwelling dementia patients--results of a controlled cluster-randomized study.
Journal: BMC health services research 20100101
Title: A new strategy for antidepressant prescription.
Journal: Frontiers in neuroscience 20100101
Title: Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials.
Journal: Alzheimer's research & therapy 20100101
Title: Recent advances in the assessment and treatment of falls in Parkinson's disease.
Journal: F1000 medicine reports 20100101
Title: Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease.
Journal: International journal of Alzheimer's disease 20100101
Title: Brain imaging of nicotinic receptors in Alzheimer's disease.
Journal: International journal of Alzheimer's disease 20100101
Title: The geriatric population and psychiatric medication.
Journal: Mens sana monographs 20100101
Title: [Cholinesterase inhibitors for treating dementia. Review].
Journal: Vertex (Buenos Aires, Argentina) 20100101
Title: Dementia.
Journal: BMJ clinical evidence 20100101
Title: Traditional used Plants against Cognitive Decline and Alzheimer Disease.
Journal: Frontiers in pharmacology 20100101
Title: The first phytochemical report of Galanthus transcaucasicus Fomin.
Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101
Title: Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.
Journal: International psychogeriatrics 20091201
Title: International price comparisons of Alzheimer's drugs: a way to close the affordability gap.
Journal: International psychogeriatrics 20091201
Title: Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine.
Journal: The Journal of pharmacology and experimental therapeutics 20091201
Title: Metabolic profiling of rat brain and cognitive behavioral tasks: potential complementary strategies in preclinical cognition enhancement research.
Journal: Journal of proteome research 20091201
Title: Comparative effectiveness research: an approach to avoiding 'overgeneralized medicine'.
Journal: Clinical and translational science 20091201
Title: Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.
Journal: Current neuropharmacology 20091201
Title: Concise syntheses of (-)-galanthamine and (+/-)-codeine via intramolecular alkylation of a phenol derivative.
Journal: Journal of the American Chemical Society 20091111
Title: Structural model for the binding sites of allosterically potentiating ligands on nicotinic acetylcholine receptors.
Journal: ChemMedChem 20091101
Title: Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
Journal: Journal of the American Geriatrics Society 20091101
Title: Packages of care for dementia in low- and middle-income countries.
Journal: PLoS medicine 20091101
Title: Can we do better in developing new drugs for Alzheimer's disease?
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association 20091101
Title: Alzheimer's disease: Seeing the signs early.
Journal: Journal of the American Academy of Nurse Practitioners 20091101
Title: Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20091101
Title: Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies.
Journal: Chemico-biological interactions 20091030
Title: Inhibition of human P-glycoprotein transport and substrate binding using a galantamine dimer.
Journal: Biochemical and biophysical research communications 20091030
Title: Effects of galantamine on L-NAME-induced behavioral impairment in Y-maze task in mice.
Journal: Neuroscience letters 20091025
Title: Galantamine is a novel post-exposure therapeutic against lethal VX challenge.
Journal: Toxicology and applied pharmacology 20091015
Title: Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia.
Journal: Behavioural brain research 20091012
Title: Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
Journal: International psychogeriatrics 20091001
Title: Trospium and cognition in patients with late onset Alzheimer disease.
Journal: The journal of nutrition, health & aging 20091001
Title: Study of acetylcholinesterase inhibitors using CE with contactless conductivity detection.
Journal: Electrophoresis 20091001
Title: Case report: combined use of donepezil and galantamine in mixed dementia.
Journal: Journal of the American Geriatrics Society 20091001
Title: Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation.
Journal: Hippocampus 20090901
Title: Misplacing objects in mild to moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial.
Journal: Journal of neurology, neurosurgery, and psychiatry 20090901
Title: Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.
Journal: Nature reviews. Drug discovery 20090901
Title: Acetylcholinesterase inhibitive activity-guided isolation of two new alkaloids from seeds of Peganum nigellastrum Bunge by an in vitro TLC- bioautographic assay.
Journal: Archives of pharmacal research 20090901
Title: Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.
Journal: PLoS medicine 20090901
Title: The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome.
Journal: Psychiatry investigation 20090901
Title: Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats.
Journal: Journal of the neurological sciences 20090815
Title: Magnesium effect on the acetylcholinesterase inhibition mechanism: a molecular chromatographic approach.
Journal: Talanta 20090815
Title: Cholinesterase inhibitory effects of the extracts and compounds of Maclura pomifera (Rafin.) Schneider.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20090801
Title: Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
Journal: Current Alzheimer research 20090801
Title: Treatment of mild cognitive impairment (MCI).
Journal: Current Alzheimer research 20090801
Title: Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease.
Journal: Brain research 20090714
Title: Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity.
Journal: Journal of natural medicines 20090701
Title: Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.
Journal: Acta pharmacologica Sinica 20090701
Title: BZYX, a novel acetylcholinesterase inhibitor, significantly improved chemicals-induced learning and memory impairments on rodents and protected PC12 cells from apoptosis induced by hydrogen peroxide.
Journal: European journal of pharmacology 20090624
Title: Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids.
Journal: Bioorganic & medicinal chemistry letters 20090615
Title: Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase.
Journal: European journal of medicinal chemistry 20090601
Title: Electroencephalographic effects of galantamine in major depressive disorder.
Journal: Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 20090601
Title: A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder.
Journal: Journal of clinical psychopharmacology 20090601
Title: [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease].
Journal: Fortschritte der Neurologie-Psychiatrie 20090601
Title: Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.
Journal: International journal of molecular sciences 20090601
Title: Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.
Journal: Dialogues in clinical neuroscience 20090601
Title: Drug-induced sialorrhoea and excessive saliva accumulation.
Journal: Prescrire international 20090601
Title: Cholinesterase based amperometric biosensors for assay of anticholinergic compounds.
Journal: Interdisciplinary toxicology 20090601
Title: Galantamine inhibits beta-amyloid aggregation and cytotoxicity.
Journal: Journal of the neurological sciences 20090515
Title: Treatment of Alzheimer's disease in the long-term-care setting.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090515
Title: Nefiracetam and galantamine modulation of excitatory and inhibitory synaptic transmission via stimulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons.
Journal: Neuroscience 20090505
Title: Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease.
Journal: International journal of geriatric psychiatry 20090501
Title: Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review.
Journal: International journal of clinical practice 20090501
Title: Cholinesterase inhibitors and beyond.
Journal: Current Alzheimer research 20090401
Title: Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.
Journal: Journal of clinical psychopharmacology 20090401
Title: Antioxidant and anticholinesterase activity evaluation of ent-kaurane diterpenoids from Sideritis arguta.
Journal: Journal of natural products 20090327
Title: Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.
Journal: Journal of chromatography. A 20090320
Title: Highly efficient, selective and sensitive molecular screening of acetylcholinesterase inhibitors of natural origin by solid-phase extraction-liquid chromatography/electrospray ionisation-octopole-orthogonal acceleration time-of-flight-mass spectrometry and novel thin-layer chromatography-based bioautography.
Journal: Journal of chromatography. A 20090320
Title: Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20090317
Title: Acteylcholinesterase inhibitor rivastigmine enhances cellular defenses in neuronal and macrophage-like cell lines.
Journal: Translational research : the journal of laboratory and clinical medicine 20090301
Title: Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation.
Journal: Biological & pharmaceutical bulletin 20090301
Title: Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
Journal: Biological & pharmaceutical bulletin 20090301
Title: Side effects of approved antidementives.
Journal: Psychiatria Danubina 20090301
Title: An unusual case of nightmares with galantamine.
Journal: Journal of the American Geriatrics Society 20090301
Title: Characteristic effects of anti-dementia drugs on rat sleep patterns.
Journal: Journal of pharmacological sciences 20090301
Title: Bullous pemphigoid precipitated by galantamine hydrobromide.
Journal: Cutis 20090301
Title: Alkaloid synthesis and accumulation in Leucojum aestivum in vitro cultures.
Journal: Natural product communications 20090301
Title: Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090301
Title: Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease.
Journal: Neuroreport 20090218
Title: Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils.
Journal: Brain research 20090213
Title: Pressurized liquid extraction and anticholinesterase activity-based thin-layer chromatography with bioautography of Amaryllidaceae alkaloids.
Journal: Analytica chimica acta 20090209
Title: Benzofurans as efficient dienophiles in normal electron demand [4 + 2] cycloadditions.
Journal: The Journal of organic chemistry 20090206
Title: Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors.
Journal: European journal of medicinal chemistry 20090201
Title: Early postnatal maternal deprivation in rats induces memory deficits in adult life that can be reversed by donepezil and galantamine.
Journal: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20090201
Title: Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.
Journal: Brain : a journal of neurology 20090201
Title: Simultaneous determination of galantamine, rivastigmine and NAP 226-90 in plasma by MEKC and its application in Alzheimer's disease.
Journal: Electrophoresis 20090201
Title: Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.
Journal: Current Alzheimer research 20090201
Title: Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
Journal: Journal of the American Geriatrics Society 20090201
Title: Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
Journal: The European journal of neuroscience 20090201
Title: [Effects of anti-dementia drugs on sleep-wake patterns in sleep-disturbed rats].
Journal: Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20090201
Title: Galantamine for dementia in people with Down syndrome.
Journal: The Cochrane database of systematic reviews 20090121
Title: Analyses of mortality risk in patients with dementia treated with galantamine.
Journal: Acta neurologica Scandinavica 20090101
Title: Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
Journal: Brain, behavior, and immunity 20090101
Title: Recent advances in treating cognitive impairment in schizophrenia.
Journal: Psychopharmacology 20090101
Title: A single in vivo application of cholinesterase inhibitors has neuron type-specific effects on nicotinic receptor activity in guinea pig hippocampus.
Journal: The Journal of pharmacology and experimental therapeutics 20090101
Title: A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease.
Journal: Journal of neurology, neurosurgery, and psychiatry 20090101
Title: Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET.
Journal: Psychopharmacology 20090101
Title: The effects of galantamine on psychopathology in chronic stable schizophrenia.
Journal: Clinical neuropharmacology 20090101
Title: [Relation between Pisa syndrome and choline esterase inhibitors in a cohort of Alzheimer's disease patients].
Journal: Presse medicale (Paris, France : 1983) 20090101
Title: The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease.
Journal: The Lancet. Neurology 20090101
Title: Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.
Journal: The Lancet. Neurology 20090101
Title: Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20090101
Title: LCMS and GCMS for the screening of alkaloids in natural and in vitro extracts of Leucojum aestivum.
Journal: Journal of natural products 20090101
Title: Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice.
Journal: British journal of pharmacology 20090101
Title: Pharmacological interventions in primary care: hopes and illusions.
Journal: Frontiers of neurology and neuroscience 20090101
Title: Is it possible to treat vascular dementia?
Journal: Frontiers of neurology and neuroscience 20090101
Title: Clinical features and diagnosis of frontotemporal dementia.
Journal: Frontiers of neurology and neuroscience 20090101
Title: Selective and irreversible inhibitors of aphid acetylcholinesterases: steps toward human-safe insecticides.
Journal: PloS one 20090101
Title: Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil.
Journal: BMC neurology 20090101
Title: Effects of Subchronic Phencyclidine (PCP) Treatment on Social Behaviors, and Operant Discrimination and Reversal Learning in C57BL/6J Mice.
Journal: Frontiers in behavioral neuroscience 20090101
Title: Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex.
Journal: Journal of Alzheimer's disease : JAD 20090101
Title: Upregulation of alpha7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides.
Journal: PloS one 20090101
Title: Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer's disease: an open-label trial.
Journal: CNS drugs 20090101
Title: Cloning and heterologous expression of a new 3'-hydroxylase gene from Lycoris radiata.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences 20090101
Title: Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network.
Journal: Dementia and geriatric cognitive disorders 20090101
Title: Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial.
Journal: Drugs & aging 20090101
Title: Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease.
Journal: CNS drugs 20090101
Title: Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately?
Journal: The open neurology journal 20090101
Title: Verbal repetition in people with mild-to-moderate Alzheimer Disease: a descriptive analysis from the VISTA clinical trial.
Journal: Alzheimer disease and associated disorders 20090101
Title: Dementia care initiative in primary practice: study protocol of a cluster randomized trial on dementia management in a general practice setting.
Journal: BMC health services research 20090101
Title: Synthesis and characterization of new galanthamine derivatives comprising peptide moiety.
Journal: Protein and peptide letters 20090101
Title: Optimized nutrient medium for galanthamine production in Leucojum aestivum L. in vitro shoot system.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences 20090101
Title: Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study.
Journal: Drugs & aging 20090101
Title: Update on the use of memantine in Alzheimer's disease.
Journal: Neuropsychiatric disease and treatment 20090101
Title: DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
Journal: Trials 20090101
Title: Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial.
Journal: Nutrition & metabolism 20090101
Title: [Galantamine (reminyl) in the treatment of severe Alzheimer's disease].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101
Title: Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial.
Journal: BMC neurology 20090101
Title: Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals.
Journal: BMC neurology 20090101
Title: Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs.
Journal: Journal of hematology & oncology 20090101
Title: Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?
Journal: Dementia and geriatric cognitive disorders 20090101
Title: The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments.
Journal: Indian journal of psychiatry 20090101
Title: Effect of abiotic and biotic elicitors on growth and alkaloid accumulation of Lycoris chinensis seedlings.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences 20090101
Title: Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesity.
Journal: BMC research notes 20090101
Title: Valproate-induced delirium in a demented patient.
Journal: Archives of gerontology and geriatrics 20090101
Title: Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease.
Journal: Alzheimer's research & therapy 20090101
Title: Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study.
Journal: CNS neuroscience & therapeutics 20090101
Title: Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.
Journal: Dementia and geriatric cognitive disorders 20090101
Title: [The use of reminyl (galantamine) in the treatment of probable vascular dementia].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101
Title: [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101
Title: Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review.
Journal: Open medicine : a peer-reviewed, independent, open-access journal 20090101
Title: Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada.
Journal: BMC health services research 20090101
Title: Current perspectives in the treatment of resistant schizophrenia.
Journal: Indian journal of psychiatry 20090101
Title: Clinical practice with antidementia and antipsychotic drugs: Audit from a geriatric clinic in India.
Journal: Indian journal of psychiatry 20090101
Title: Pharmacokinetic Study of a Novel Antihyperlipidemic Agent LM-13765- A Prodrug.
Journal: Indian journal of pharmaceutical sciences 20090101
Title: Modeling the cost-effectiveness of galantamine for mild to moderately severe Alzheimer's disease in Korea.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101
Title: Mild cognitive impairment: The dilemma.
Journal: Indian journal of psychiatry 20090101
Title: Vascular cognitive impairment.
Journal: Indian journal of psychiatry 20090101
Title: Frontotemporal dementia: An updated overview.
Journal: Indian journal of psychiatry 20090101
Title: Memory clinics in context.
Journal: Indian journal of psychiatry 20090101
Title: Behavioral and psychological symptoms of dementia and their management.
Journal: Indian journal of psychiatry 20090101
Title: Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia.
Journal: Indian journal of psychiatry 20090101
Title: Screening the methanol extracts of some Iranian plants for acetylcholinesterase inhibitory activity.
Journal: Research in pharmaceutical sciences 20090101
Title: Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
Journal: Neuroscience letters 20081219
Title: Association mechanism of four acetylcholinesterase inhibitors (AChEIs) with human serum albumin: a biochromatographic approach.
Journal: Journal of pharmaceutical and biomedical analysis 20081215
Title: Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine.
Journal: Journal of neurology, neurosurgery, and psychiatry 20081201
Title: Monitoring enzyme reaction and screening of inhibitors of acetylcholinesterase by quantitative matrix-assisted laser desorption/ionization Fourier transform mass spectrometry.
Journal: Journal of the American Society for Mass Spectrometry 20081201
Title: Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.
Journal: Neuroscience research 20081201
Title: Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease.
Journal: American journal of Alzheimer's disease and other dementias 20081201
Title: Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine*.
Journal: Current medical research and opinion 20081201
Title: Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension.
Journal: American journal of Alzheimer's disease and other dementias 20081201
Title: Acetylcholinesterase-inhibiting activity of pyrrole derivatives from a novel marine gliding bacterium, Rapidithrix thailandica.
Journal: Marine drugs 20081201
Title: Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer's disease: a meta-analysis.
Journal: Clinical interventions in aging 20081201
Title: Effects of cholinotropic and cytostatic drugs on the development of Arthus reaction.
Journal: Bulletin of experimental biology and medicine 20081201
Title: Quantitation of donepezil and its active metabolite 6-O-desmethyl donepezil in human plasma by a selective and sensitive liquid chromatography-tandem mass spectrometric method.
Journal: Analytica chimica acta 20081123
Title: Nicotinic acetylcholine receptors and modulation of learning in 4- and 27-month-old rabbits.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081101
Title: Evaluation of galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: part I.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20081101
Title: Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial).
Journal: Neuroscience and behavioral physiology 20081101
Title: [Bradycardia induced by galantamine].
Journal: Annales francaises d'anesthesie et de reanimation 20081101
Title: Vesicular acetylcholine transporter (VAChT) in the brain of spontaneously hypertensive rats (SHR): effect of treatment with an acetylcholinesterase inhibitor.
Journal: Clinical and experimental hypertension (New York, N.Y. : 1993) 20081101
Title: Relative tolerability of Alzheimer's disease treatments.
Journal: Psychiatry (Edgmont (Pa. : Township)) 20081101
Title: Domino double Michael-Claisen cyclizations: a powerful general tool for introducing quaternary stereocenters at C4 of cyclohexane-1,3-diones and total synthesis of diverse families of sterically congested alkaloids.
Journal: The Journal of organic chemistry 20081003
Title: Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial.
Journal: International psychogeriatrics 20081001
Title: Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat.
Journal: British journal of pharmacology 20081001
Title: Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitro.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20081001
Title: Diagnosis and management of Parkinson's disease dementia.
Journal: International journal of clinical practice 20081001
Title: Errorless learning and spaced retrieval techniques to relearn instrumental activities of daily living in mild Alzheimer's disease: A case report study.
Journal: Neuropsychiatric disease and treatment 20081001
Title: Neuropharmacology.
Journal: Indian journal of pharmacology 20081001
Title: Flexibility versus 'rigidity' of the functional architecture of AChE active center.
Journal: Chemico-biological interactions 20080925
Title: Study of neuroprotection of donepezil, a therapy for Alzheimer's disease.
Journal: Chemico-biological interactions 20080925
Title: Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease.
Journal: Chemico-biological interactions 20080925
Title: Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6).
Journal: Journal of psychopharmacology (Oxford, England) 20080901
Title: Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats.
Journal: The international journal of neuropsychopharmacology 20080901
Title: An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20080901
Title: Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
Journal: The Lancet. Neurology 20080901
Title: Spinal p38 MAP kinase regulates peripheral cholinergic outflow.
Journal: Arthritis and rheumatism 20080901
Title: [Galantamine].
Journal: Revue de l'infirmiere 20080901
Title: [Galantamine therapy in dementia associated with CADASIL].
Journal: Revista de neurologia 20080901
Title: The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080901
Title: Drug utilization review of cholinesterase inhibitors in Quebec.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20080901
Title: Role of the central cholinergic system in the therapeutics of schizophrenia.
Journal: Current neuropharmacology 20080901
Title: Solid-phase synthesis and biological evaluation of a parallel library of 2,3-dihydro-1,5-benzothiazepines.
Journal: Bioorganic & medicinal chemistry 20080815
Title: PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD.
Journal: Neurobiology of aging 20080801
Title: Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.
Journal: Schizophrenia research 20080801
Title: The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.
Journal: Epilepsy & behavior : E&B 20080801
Title: Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia.
Journal: Schizophrenia research 20080801
Title: Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries.
Journal: Natural product reports 20080801
Title: A nonlinear mixed effects IVIVC model for multi-release drug delivery systems.
Journal: Journal of pharmacokinetics and pharmacodynamics 20080801
Title: Rivastigmine transdermal patch: role in the management of Alzheimer's disease.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20080801
Title: The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na, K)-, Mg-ATPase activities, antioxidant status, and learning performance of aged rats.
Journal: Neuropsychiatric disease and treatment 20080801
Title: Current approaches to the treatment of Parkinson's disease.
Journal: Neuropsychiatric disease and treatment 20080801
Title: Present and prospective clinical therapeutic regimens for Alzheimer's disease.
Journal: Neuropsychiatric disease and treatment 20080801
Title: Psychiatric disorders and traumatic brain injury.
Journal: Neuropsychiatric disease and treatment 20080801
Title: Extracts and constituents of Leontopodium alpinum enhance cholinergic transmission: brain ACh increasing and memory improving properties.
Journal: Biochemical pharmacology 20080715
Title: High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.
Journal: Schizophrenia research 20080701
Title: Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.
Journal: Molecular pharmacology 20080701
Title: Prevalence of cholinesterase inhibitors in subjects with dementia in Europe.
Journal: Pharmacoepidemiology and drug safety 20080701
Title: Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp.
Journal: Bioorganic & medicinal chemistry 20080701
Title: Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20080701
Title: Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
Journal: Journal of medicinal chemistry 20080612
Title: The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study.
Journal: Journal of psychiatric research 20080601
Title: A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.
Journal: International journal of geriatric psychiatry 20080601
Title: Galantamine as an adjunctive treatment in major depression.
Journal: Journal of clinical psychopharmacology 20080601
Title: Hydrogen-bonding properties of galanthamine: an investigation through crystallographic database observations and computational chemistry.
Journal: Acta crystallographica. Section B, Structural science 20080601
Title: Galantamine-induced pisa syndrome: memantine as an alternative.
Journal: International journal of geriatric psychiatry 20080601
Title: Butyrylcholinesterase, lipoxygenase inhibiting and antifungal alkaloids from Isatis tinctoria.
Journal: Journal of enzyme inhibition and medicinal chemistry 20080601
Title: Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.
Journal: Journal of managed care pharmacy : JMCP 20080601
Title: Cost-effectiveness of drug therapies for Alzheimer's disease: A brief review.
Journal: Neuropsychiatric disease and treatment 20080601
Title: Safety and efficacy of galantamine in subjects with mild cognitive impairment.
Journal: Neurology 20080527
Title: Treatment for MCI: is the evidence sufficient?
Journal: Neurology 20080527
Title: Dementia medications in palliative care #174.
Journal: Journal of palliative medicine 20080501
Title: Galantamine improves gait performance in patients with Alzheimer's disease.
Journal: Journal of the American Geriatrics Society 20080501
Title: [Treatment of Alzheimer's disease: status quo and future considerations].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20080501
Title: Diagnosis and treatment of dementia with Lewy bodies.
Journal: JAAPA : official journal of the American Academy of Physician Assistants 20080501
Title: 3-(3-Chloro-prop-yl)-7,8-dimeth-oxy-2,3,4,5-tetra-hydro-1H-3-benzazepin-2-one at 125 K.
Journal: Acta crystallographica. Section E, Structure reports online 20080501
Title: 3-(3-Chloro-prop-yl)-7,8-dimeth-oxy-1H-3-benzazepin-2(3H)-one at 125 K.
Journal: Acta crystallographica. Section E, Structure reports online 20080501
Title: Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties.
Journal: Bioorganic & medicinal chemistry 20080415
Title: AAFP and ACP release guideline on dementia treatment.
Journal: American family physician 20080415
Title: For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?
Journal: International psychogeriatrics 20080401
Title: Inhibition of cholinesterase and amyloid-beta aggregation by resveratrol oligomers from Vitis amurensis.
Journal: Phytotherapy research : PTR 20080401
Title: N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum.
Journal: Bioorganic & medicinal chemistry letters 20080401
Title: [Treatment pattern of Alzheimer's disease with cholinesterase inhibitors (TRAIN study)].
Journal: Revista de neurologia 20080401
Title: Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer's disease.
Journal: Neuropsychiatric disease and treatment 20080401
Title: Galantamine and carbon monoxide protect brain microvascular endothelial cells by heme oxygenase-1 induction.
Journal: Biochemical and biophysical research communications 20080314
Title: Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations.
Journal: Annals of internal medicine 20080304
Title: Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.
Journal: Annals of internal medicine 20080304
Title: Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.
Journal: Annals of internal medicine 20080304
Title: The partial alpha7 nicotine acetylcholine receptor agonist S 24795 enhances long-term potentiation at CA3-CA1 synapses in the adult mouse hippocampus.
Journal: Neuropharmacology 20080301
Title: Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells.
Journal: Neurotoxicology 20080301
Title: [Antidementia drugs--response or non-response?].
Journal: Der Internist 20080301
Title: How long can patients with mild or moderate Alzheimer's dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study.
Journal: European journal of neurology 20080301
Title: Pharmacodynamics of memantine: an update.
Journal: Current neuropharmacology 20080301
Title: Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine.
Journal: Neurobiology of aging 20080201
Title: Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
Journal: International journal of geriatric psychiatry 20080201
Title: A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.
Journal: International journal of geriatric psychiatry 20080201
Title: Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months.
Journal: International journal of geriatric psychiatry 20080201
Title: Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080201
Title: Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention.
Journal: International journal of geriatric psychiatry 20080201
Title: Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.
Journal: Psychopharmacology 20080201
Title: Prolonged QT interval, syncope, and delirium with galantamine.
Journal: The Annals of pharmacotherapy 20080201
Title: Neurotrophic factors in Alzheimer's disease: role of axonal transport.
Journal: Genes, brain, and behavior 20080201
Title: Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.
Journal: Current Alzheimer research 20080201
Title: Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-week prospective study.
Journal: Journal of Korean medical science 20080201
Title: Pharmacologic management of Alzheimer disease.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20080201
Title: The mechanisms of neurodegenerative processes and current pharmacotherapy of Alzheimer's disease.
Journal: Georgian medical news 20080201
Title: [Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20080131
Title: Cholinesterase inhibitors for delirium.
Journal: The Cochrane database of systematic reviews 20080123
Title: [Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
Journal: Der Nervenarzt 20080101
Title: Galantamine for the treatment of cognitive impairments in people with schizophrenia.
Journal: The American journal of psychiatry 20080101
Title: Education and use of dementia drugs: a register-based study of over 600,000 older people.
Journal: Dementia and geriatric cognitive disorders 20080101
Title: Galantamine in Alzheimer's disease.
Journal: Expert review of neurotherapeutics 20080101
Title: Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
Journal: Journal of neuroinflammation 20080101
Title: Galantamine in frontotemporal dementia and primary progressive aphasia.
Journal: Dementia and geriatric cognitive disorders 20080101
Title: Gliomatosis cerebri presenting as rapidly progressive dementia and parkinsonism in an elderly woman: a case report.
Journal: Journal of medical case reports 20080101
Title: First administration of cytidine diphosphocholine and galantamine in schizophrenia: a sustained alpha7 nicotinic agonist strategy.
Journal: Clinical neuropharmacology 20080101
Title: Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil.
Journal: Alzheimer disease and associated disorders 20080101
Title: Pharmacogenomics in Alzheimer's disease.
Journal: Methods in molecular biology (Clifton, N.J.) 20080101
Title: [Treatment of Alzheimer's Disease cognitive symptoms].
Journal: Vertex (Buenos Aires, Argentina) 20080101
Title: Analysis of galanthamine-type alkaloids by capillary gas chromatography-mass spectrometry in plants.
Journal: Phytochemical analysis : PCA 20080101
Title: New rapid validated HPTLC method for the determination of galanthamine in Amaryllidaceae plant extracts.
Journal: Phytochemical analysis : PCA 20080101
Title: Rapid TLC/GC-MS identification of acetylcholinesterase inhibitors in alkaloid extracts.
Journal: Phytochemical analysis : PCA 20080101
Title: Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's.
Journal: BMC health services research 20080101
Title: Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease: results from the GALATEA multicentre, observational study.
Journal: Clinical drug investigation 20080101
Title: The clinical significance of plasmatic amyloid A{beta}-40 peptide levels in Alzheimer's disease patients treated with galantamine.
Journal: American journal of Alzheimer's disease and other dementias 20080101
Title: One-week dose titration of extended release galantamine in patients with Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association 20080101
Title: Review of issue: studies on veterans, a useful pain scale, and plasma amyloid levels as a predictor of response to medications.
Journal: American journal of Alzheimer's disease and other dementias 20080101
Title: [Combined use of reminyl (galanthamine) and ovestin (oestradiol) for the treatment of cognitive disorders in women with hypoestrogenic syndrome].
Journal: Eksperimental'naia i klinicheskaia farmakologiia 20080101
Title: Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
Journal: Clinical interventions in aging 20080101
Title: Combined models for data from in vitro-in vivo correlation experiments.
Journal: Journal of biopharmaceutical statistics 20080101
Title: The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodies.
Journal: Current medicinal chemistry 20080101
Title: Neurological and psychiatric practitioners' views on Alzheimer's disease and treatment thereof.
Journal: Dementia and geriatric cognitive disorders 20080101
Title: Genomic NGFB variation and multiple sclerosis in a case control study.
Journal: BMC medical genetics 20080101
Title: Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease.
Journal: BMC neuroscience 20080101
Title: Intranasal administration of acetylcholinesterase inhibitors.
Journal: BMC neuroscience 20080101
Title: Electrically enhanced and controlled drug delivery through buccal mucosa.
Journal: Acta poloniae pharmaceutica 20080101
Title: Discontinuing Alzheimer's disease drug therapy: why, when, and how.
Journal: Director (Cincinnati, Ohio) 20080101
Title: Chronic fatigue syndrome.
Journal: BMJ clinical evidence 20080101
Title: Once-daily transdermal rivastigmine in the treatment of Alzheimer's disease.
Journal: Drug design, development and therapy 20080101
Title: Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program.
Journal: Patient preference and adherence 20080101
Title: Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease.
Journal: Journal of inflammation research 20080101
Title: Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy.
Journal: Stroke 20071201
Title: An update on the pharmacology of galantamine.
Journal: Expert opinion on investigational drugs 20071201
Title: Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
Journal: Psychiatry and clinical neurosciences 20071201
Title: Management of the behavioral and psychological symptoms of dementia.
Journal: Clinical interventions in aging 20071201
Title: The challenge of supporting care for dementia in primary care.
Journal: Clinical interventions in aging 20071201
Title: Rivastigmine in Alzheimer's disease: Cognitive function and quality of life.
Journal: Therapeutics and clinical risk management 20071201
Title: Rivastigmine for the treatment of dementia associated with Parkinson's disease.
Journal: Neuropsychiatric disease and treatment 20071201
Title: Rivastigmine in Chinese patients with subcortical vascular dementia.
Journal: Neuropsychiatric disease and treatment 20071201
Title: Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.
Journal: Current neuropharmacology 20071201
Title: Current therapeutic options for Alzheimer's disease.
Journal: Current genomics 20071201
Title: New potent acetylcholinesterase inhibitors in the tetracyclic triterpene series.
Journal: Journal of medicinal chemistry 20071101
Title: Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.
Journal: PLoS medicine 20071101
Title: Suzuki-Miyaura and Stille reactions as key steps in the synthesis of diversely functionalized Amaryllidaceae alkaloid analogs bearing a 5,6,7,8-tetrahydrobenzo[c,e]azocine skeleton.
Journal: Combinatorial chemistry & high throughput screening 20071101
Title: Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society 20071015
Title: Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.
Journal: Neurology 20071009
Title: Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease.
Journal: Journal of medicinal chemistry 20071004
Title: Impairments in trace EB conditioning by knife-cut lesions to the fornix in rabbits: reversal by galantamine.
Journal: Neurobiology of learning and memory 20071001
Title: Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries.
Journal: Journal of the American Geriatrics Society 20071001
Title: Evaluation of centrally acting cholinesterase inhibitor exposures in adults.
Journal: The Annals of pharmacotherapy 20071001
Title: Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Journal: Prescrire international 20071001
Title: Pharmacotherapy of Alzheimer disease.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie 20071001
Title: [Cardiovascular effects of cholinesterase inhibitors in Alzheimer's disease].
Journal: Revue neurologique 20071001
Title: Diagnosis and management of vascular cognitive impairment.
Journal: Current atherosclerosis reports 20071001
Title: [The localization of galanthamine in vegetative organ of Lycoris aurea Herb].
Journal: Fen zi xi bao sheng wu xue bao = Journal of molecular cell biology 20071001
Title: Progress update: Pharmacological treatment of Alzheimer's disease.
Journal: Neuropsychiatric disease and treatment 20071001
Title: Management of dementia with a cerebrovascular component.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association 20071001
Title: [Are anti-dementia drugs worthwhile?].
Journal: MMW Fortschritte der Medizin 20070913
Title: Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis.
Journal: International journal of geriatric psychiatry 20070901
Title: Statins prevent cholinesterase inhibitor blockade of sympathetic alpha7-nAChR-mediated currents in rat superior cervical ganglion neurons.
Journal: American journal of physiology. Heart and circulatory physiology 20070901
Title: Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission.
Journal: Neuropharmacology 20070901
Title: Motor-skill learning in Alzheimer's disease: a review with an eye to the clinical practice.
Journal: Neuropsychology review 20070901
Title: Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
Journal: The Lancet. Neurology 20070901
Title: VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux.
Journal: Neuropharmacology 20070901
Title: Anti-dementia drugs and hippocampal-dependent memory in rodents.
Journal: Behavioural pharmacology 20070901
Title: Benzylphenethylamine alkaloids from Hosta plantaginea with inhibitory activity against tobacco mosaic virus and acetylcholinesterase.
Journal: Journal of natural products 20070901
Title: Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics.
Journal: Current Alzheimer research 20070901
Title: NICE judgement leaves behind a nasty taste.
Journal: Nursing older people 20070901
Title: [Cholinergic hypothesis in psychosis following traumatic brain injury and cholinergic hypothesis in schizophrenia: a link?].
Journal: L'Encephale 20070901
Title: Vascular dementia: pharmacological treatment approaches and perspectives.
Journal: Clinical interventions in aging 20070901
Title: The enantioselective synthesis of (-)-lycoramine with the Birch-Cope sequence.
Journal: The Journal of organic chemistry 20070831
Title: Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial.
Journal: Neurology 20070821
Title: Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils.
Journal: The Journal of pharmacology and experimental therapeutics 20070801
Title: Galantamine treatment of vascular dementia: a randomized trial.
Journal: Neurology 20070731
Title: Leishmanicidal and cholinesterase inhibiting activities of phenolic compounds from Allanblackia monticola and Symphonia globulifera.
Journal: Molecules (Basel, Switzerland) 20070720
Title: Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease.
Journal: Magnetic resonance imaging 20070701
Title: Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.
Journal: The Journal of pharmacology and experimental therapeutics 20070701
Title: Magnetic resonance imaging predictors of cognition in mild cognitive impairment.
Journal: Archives of neurology 20070701
Title: Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology.
Journal: Journal of Alzheimer's disease : JAD 20070701
Title: Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Journal: Methods and findings in experimental and clinical pharmacology 20070701
Title: High-performance liquid chromatographic method with UV photodiode-array, fluorescence and mass spectrometric detection for simultaneous determination of galantamine and its phase I metabolites in biological samples.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070615
Title: Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
Journal: Journal of molecular biology 20070615
Title: Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats.
Journal: The international journal of neuropsychopharmacology 20070601
Title: Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070601
Title: The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070601
Title: The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys.
Journal: The Journal of pharmacology and experimental therapeutics 20070601
Title: Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future.
Journal: International psychogeriatrics 20070601
Title: Memory enhancing drugs and Alzheimer's disease: enhancing the self or preventing the loss of it?
Journal: Medicine, health care, and philosophy 20070601
Title: EXACT: rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease.
Journal: International journal of clinical practice 20070601
Title: [Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies].
Journal: Deutsche medizinische Wochenschrift (1946) 20070601
Title: [Galanthamine versus donepezil in the treatment of Alzheimer's disease].
Journal: Revista de neurologia 20070601
Title: [Rivastigmine solution prescribing habits in patients with Alzheimer-type dementia in Spain (RIVASOL study)].
Journal: Revista de neurologia 20070601
Title: Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Journal: Medicine and health, Rhode Island 20070601
Title: Synthesis of 6beta-D-glucosyl and 6-nitroxy (-)-galanthamine derivatives as acetylcholinesterase inhibitors.
Journal: Die Pharmazie 20070601
Title: A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels.
Journal: Journal of Alzheimer's disease : JAD 20070601
Title: Treating senile dementia with traditional Chinese medicine.
Journal: Clinical interventions in aging 20070601
Title: Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
Journal: Recent patents on CNS drug discovery 20070601
Title: Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics.
Journal: Neuropsychiatric disease and treatment 20070601
Title: Mechanisms of over-activated innate immune system regulation in autoimmune and neurodegenerative disorders.
Journal: Neuropsychiatric disease and treatment 20070601
Title: A case of disseminated polycystic dilated perivascular spaces presenting with dementia and parkinsonism.
Journal: Journal of clinical neurology (Seoul, Korea) 20070601
Title: [Acetylcholinesterase inhibitors for dementia--an update].
Journal: MMW Fortschritte der Medizin 20070521
Title: Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
Journal: Neurology 20070515
Title: Stereocontrolled synthesis of (-)-galanthamine.
Journal: Organic letters 20070510
Title: Effective pharmacologic management of Alzheimer's disease.
Journal: The American journal of medicine 20070501
Title: In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo.
Journal: International journal of pharmaceutics 20070420
Title: Methyl 2-(2-(4-formylphenoxy)acetamido)-2-substituted acetate derivatives: a new class of acetylcholinesterase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20070415
Title: Post-ischemic continuous administration of galantamine attenuates cognitive deficits and hippocampal neurons loss after transient global ischemia in gerbils.
Journal: Neuroscience letters 20070406
Title: Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial.
Journal: Neurology 20070403
Title: Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
Journal: International journal of geriatric psychiatry 20070401
Title: Acetylcholine and cognition in schizophrenia: effects of galantamine.
Journal: Current psychiatry reports 20070401
Title: The influence of galantamine on reaction time, attention processes, and performance variability in elderly Alzheimer patients.
Journal: Journal of clinical psychopharmacology 20070401
Title: Rivastigmine in the treatment of patients with Alzheimer's disease.
Journal: Neuropsychiatric disease and treatment 20070401
Title: Memantine: efficacy and safety in mild-to-severe Alzheimer's disease.
Journal: Neuropsychiatric disease and treatment 20070401
Title: Refractory psychosis and prominent cognitive deficits in a patient with mega-cisterna magna.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20070330
Title: Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine.
Journal: Age and ageing 20070301
Title: A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
Journal: International clinical psychopharmacology 20070301
Title: A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
Journal: International journal of clinical practice 20070301
Title: Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.
Journal: Neuropharmacology 20070301
Title: Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Journal: Pharmacotherapy 20070301
Title: Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
Journal: The Journal of clinical psychiatry 20070301
Title: Pharmacokinetics and bioequivalence studies of galantamine hydrobromide dispersible tablet in healthy male Chinese volunteers.
Journal: Drug development and industrial pharmacy 20070301
Title: Frontotemporal dementia: recommendations for therapeutic studies, designs, and approaches.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20070301
Title: Rivastigmine in the treatment of Alzheimer's disease: an update.
Journal: Clinical interventions in aging 20070301
Title: Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats.
Journal: Neuropharmacology 20070201
Title: Anti-Alzheimer drugs: life-threatening adverse effects.
Journal: Prescrire international 20070201
Title: Quantitative determination of galantamine in human plasma by sensitive liquid chromatography-tandem mass spectrometry using loratadine as an internal standard.
Journal: Journal of chromatographic science 20070201
Title: Impaired cognition and attention in adults: pharmacological management strategies.
Journal: Neuropsychiatric disease and treatment 20070201
Title: Nicotinic component of galantamine in the regulation of amyloid precursor protein processing.
Journal: Chemico-biological interactions 20070130
Title: Changes of cholinesterase activities in the plasma and some tissues following administration of L-carnitine and galanthamine to rats.
Journal: Neuroscience letters 20070116
Title: Preparation of secolycorines against acetylcholinesterase.
Journal: Bioorganic & medicinal chemistry 20070115
Title: Development of in situ ion selective sensors for dissolution.
Journal: Analytica chimica acta 20070102
Title: Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101
Title: Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20070101
Title: Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
Journal: Synapse (New York, N.Y.) 20070101
Title: Treatment of vascular dementia and vascular cognitive impairment.
Journal: The neurologist 20070101
Title: Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials.
Journal: Drugs & aging 20070101
Title: Effect of a M1 allosteric modulator on scopolamine-induced amnesia.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates)) 20070101
Title: Galantamine and QTc prolongation.
Journal: The Journal of clinical psychiatry 20070101
Title: Posttraumatic stress disorder-like symptoms after treatment with acetylcholinesterase inhibitors.
Journal: The Journal of neuropsychiatry and clinical neurosciences 20070101
Title: Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis.
Journal: Drugs & aging 20070101
Title: Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
Journal: Archives of gerontology and geriatrics 20070101
Title: Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient.
Journal: Archives of gerontology and geriatrics 20070101
Title: Results of galantamine treatment in acute traumatic brain injury.
Journal: Psychosomatics 20070101
Title: Cholinesterase inhibitors in mild cognitive impairment: a meta-analysis of randomized controlled trials.
Journal: Neurologia i neurochirurgia polska 20070101
Title: Brain activation in elderly people with and without dementia: Influences of gender and medication.
Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20070101
Title: Naturalistic treatment of Alzheimer's disease with galantamine: 12-month follow-up from the NATURE study.
Journal: CNS drugs 20070101
Title: Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
Journal: Dementia and geriatric cognitive disorders 20070101
Title: Galantamine for Alzheimer's disease and mild cognitive impairment.
Journal: Neuroepidemiology 20070101
Title: Risk and predictability of drug interactions in the elderly.
Journal: International review of neurobiology 20070101
Title: Advancing translational research with the Semantic Web.
Journal: BMC bioinformatics 20070101
Title: Galantamine effects on memory, spatial cue utilization, and neurotrophic factors in aged female rats.
Journal: Cell transplantation 20070101
Title: Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO.
Journal: BMC pharmacology 20070101
Title: [EEG and clinical psychophysiological study of functional changes in the chronic ischemic brain with increased acetylcholinergic activity].
Journal: Fiziologiia cheloveka 20070101
Title: Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice.
Journal: BMC neuroscience 20070101
Title: The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial.
Journal: BMC neurology 20070101
Title: Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2.
Journal: Clinical neuropharmacology 20070101
Title: Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis.
Journal: PharmacoEconomics 20070101
Title: [Alzheimer drugs for mild cognitive impairment].
Journal: Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20070101
Title: [Criminal clozapine intoxications].
Journal: Anesteziologiia i reanimatologiia 20070101
Title: Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?
Journal: Drugs & aging 20070101
Title: Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).
Journal: Drug safety 20070101
Title: Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.
Journal: Current medicinal chemistry 20070101
Title: Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis.
Journal: Journal of neural transmission. Supplementum 20070101
Title: Brain type carnosinase in dementia: a pilot study.
Journal: BMC neurology 20070101
Title: What are the benefits of cognitive enhancers for Alzheimer's Disease: use of Population Impact Measures.
Journal: BMC geriatrics 20070101
Title: NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?
Journal: PharmacoEconomics 20070101
Title: Alkaloid variability in Leucojum aestivum from wild populations.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences 20070101
Title: In vitro anticholinesterase activity of various alkaloids.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences 20070101
Title: Short term response is predictive of long term response to acetylcholinesterase inhibitors in Alzheimer's disease: a starting point to explore Bayesian approximation in clinical practice.
Journal: Bioinformation 20070101
Title: [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101
Title: Cholinesterase inhibitor blockade and its prevention by statins of sympathetic alpha7-nAChR-mediated cerebral nitrergic neurogenic vasodilation.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20061201
Title: Potential medicinal plants for CNS disorders: an overview.
Journal: Phytotherapy research : PTR 20061201
Title: Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review.
Journal: Schizophrenia research 20061201
Title: In vitro galantamine-memantine co-application: mechanism of beneficial action.
Journal: Neuropharmacology 20061201
Title: The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.
Journal: British journal of pharmacology 20061201
Title: Biomimetic synthesis of (+/-)-galanthamine and asymmetric synthesis of (-)-galanthamine using remote asymmetric induction.
Journal: Chemical & pharmaceutical bulletin 20061201
Title: Effect of galantamine on acetylcholinesterase and butyrylcholinesterase activities in the presence of L-carnitine in rat selected brain and peripheral tissues.
Journal: Neuro endocrinology letters 20061201
Title: Evidence-Based Research in Complementary and Alternative Medicine III: Treatment of Patients with Alzheimer's Disease.
Journal: Evidence-based complementary and alternative medicine : eCAM 20061201
Title: Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial.
Journal: International journal of clinical pharmacology and therapeutics 20061201
Title: 6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20061115
Title: Micellar electrokinetic chromatography-electrospray ionization mass spectrometry for the identification of drug impurities.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061107
Title: Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity.
Journal: European journal of pharmacology 20061107
Title: Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
Journal: Journal of psychopharmacology (Oxford, England) 20061101
Title: Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.
Journal: Journal of psychiatry & neuroscience : JPN 20061101
Title: Blockade of Ca2+ -activated K+ channels by galantamine can also contribute to the potentiation of catecholamine secretion from chromaffin cells.
Journal: European journal of pharmacology 20061024
Title: Augmentation of near infrared diffuse reflectance and transmittance spectral data for the development of robust PLSBC models for classifying double blind clinical trial tablets.
Journal: Journal of pharmaceutical and biomedical analysis 20061011
Title: [Medical treatment of Alzheimer's disease].
Journal: Ugeskrift for laeger 20061002
Title: [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].
Journal: Revista de neurologia 20061001
Title: Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
Journal: Mayo Clinic proceedings 20061001
Title: A prospective, open-label trial of galantamine in autistic disorder.
Journal: Journal of child and adolescent psychopharmacology 20061001
Title: Galantamine improves cognition in schizophrenic patients stabilized on risperidone.
Journal: Biological psychiatry 20060915
Title: Analysis of Amaryllidaceae alkaloids from Narcissus by GC-MS and capillary electrophoresis.
Journal: Journal of pharmaceutical and biomedical analysis 20060911
Title: Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase.
Journal: Journal of medicinal chemistry 20060907
Title: Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20060901
Title: Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.
Journal: The Journal of pharmacology and experimental therapeutics 20060901
Title: Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade.
Journal: Neuropharmacology 20060901
Title: [Risperidone and cerebrovascular adverse effects in elderly patients with dementia].
Journal: Revista clinica espanola 20060901
Title: Harmless herbs? Think again: merits of a complete medication history.
Journal: Journal of the American Medical Directors Association 20060901
Title: Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: deficits induced by scopolamine and by prolonging the retention interval.
Journal: Pharmacology, biochemistry, and behavior 20060901
Title: Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana.
Journal: Journal of natural products 20060901
Title: Adjuvant galantamine for cognitive dysfunction in a patient with bipolar disorder.
Journal: Journal of psychiatric practice 20060901
Title: Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
Journal: The American journal of geriatric pharmacotherapy 20060901
Title: [Plant metabolites as nootropics and cognitives].
Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 20060901
Title: Vascular dementia: prevention and treatment.
Journal: Clinical interventions in aging 20060901
Title: Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20060829
Title: [Advances in Alzheimer's disease treatment].
Journal: La Revue de medecine interne 20060801
Title: [Cholinesterase inhibitor therapy in long term care settings].
Journal: La Revue de medecine interne 20060801
Title: [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease].
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060801
Title: Alzheimer's disease.
Journal: Lancet (London, England) 20060729
Title: [Mortality-associated factors in patients with Alzheimer's disease treated with galantamine].
Journal: Medicina clinica 20060708
Title: Galantamine added to antipsychotic treatment in chronic schizophrenia: cognitive improvement?
Journal: Schizophrenia research 20060701
Title: Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.
Journal: Age and ageing 20060701
Title: Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.
Journal: Schizophrenia research 20060701
Title: Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
Journal: Journal of clinical pharmacology 20060701
Title: Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Journal: Journal of clinical pharmacology 20060701
Title: Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060701
Title: Choline pivaloyl ester strengthened the benefit effects of Tacrine and Galantamine on electroencephalographic and cognitive performances in nucleus basalis magnocellularis-lesioned and aged rats.
Journal: Pharmacology, biochemistry, and behavior 20060701
Title: Effects of galantamine and donepezil on active and passive avoidance tests in rats with induced hypoxia.
Journal: Journal of pharmacological sciences 20060701
Title: Dementia with lewy bodies: therapeutic opportunities and pitfalls.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060701
Title: Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas.
Journal: The Journal of pharmacology and experimental therapeutics 20060601
Title: Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery.
Journal: Journal of pharmaceutical sciences 20060601
Title: Vobasinyl-iboga bisindole alkaloids, potent acetylcholinesterase inhibitors from Tabernaemontana divaricata root.
Journal: The Journal of pharmacy and pharmacology 20060601
Title: Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Journal: Prescrire international 20060601
Title: Once-daily formulation of galantamine.
Journal: Journal of the American Medical Directors Association 20060601
Title: [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
Journal: Medizinische Monatsschrift fur Pharmazeuten 20060601
Title: Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
Journal: The American journal of geriatric pharmacotherapy 20060601
Title: Treatment of Alzheimer's disease across the spectrum of severity.
Journal: Clinical interventions in aging 20060601
Title: Economic considerations in the management of Alzheimer's disease.
Journal: Clinical interventions in aging 20060601
Title: Memantine combined with an acetyl cholinesterase inhibitor - hope for the future?
Journal: Neuropsychiatric disease and treatment 20060601
Title: [Anti-dementia drugs for dementia syndromes--just unkept promises?].
Journal: MMW Fortschritte der Medizin 20060515
Title: Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen.
Journal: International journal of clinical practice 20060501
Title: Bioactive diterpenes from the fruits of Detarium microcarpum.
Journal: Journal of natural products 20060501
Title: Quantification of metaxalone in human plasma by liquid chromatography coupled to tandem mass spectrometry.
Journal: Journal of analytical toxicology 20060501
Title: [Complete atrioventricular block during galantamine therapy].
Journal: Nederlands tijdschrift voor geneeskunde 20060429
Title: Total synthesis of (+/-)-galanthamine.
Journal: Organic letters 20060427
Title: Alzheimer's disease drugs promote neurogenesis.
Journal: Brain research 20060426
Title: High-performance liquid chromatography-mass spectrometry-based acetylcholinesterase assay for the screening of inhibitors in natural extracts.
Journal: Journal of chromatography. A 20060421
Title: Isoquinoline derivatives as potential acetylcholinesterase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20060415
Title: An innovative approach to involve patients in measuring treatment effects in drug trials.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20060411
Title: Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20060411
Title: Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.
Journal: Journal of medicinal chemistry 20060406
Title: Clinical trials in mild cognitive impairment: lessons for the future.
Journal: Journal of neurology, neurosurgery, and psychiatry 20060401
Title: Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice.
Journal: The Journal of pharmacology and experimental therapeutics 20060401
Title: Accurate product ion mass spectra of galanthamine derivatives.
Journal: Journal of mass spectrometry : JMS 20060401
Title: Galantamine treatment of cognitive impairment in bipolar disorder: four cases.
Journal: Bipolar disorders 20060401
Title: Cholinesterase inhibitors: drugs looking for a disease?
Journal: PLoS medicine 20060401
Title: [Anticholinesterases in the treatment of Alzheimer's disease].
Journal: Revista de neurologia 20060401
Title: A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study.
Journal: Journal of clinical psychopharmacology 20060401
Title: Antiamnesic effect of combined treatment with galantamine and estradiol in middle-aged ovariectomized female rats.
Journal: Bulletin of experimental biology and medicine 20060401
Title: Do cholinergic therapies have disease-modifying effects in Alzheimer's disease?
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association 20060401
Title: Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase.
Journal: Bioorganic & medicinal chemistry 20060315
Title: [Complete atrioventricular block during galantamine therapy].
Journal: Nederlands tijdschrift voor geneeskunde 20060311
Title: Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
Journal: Journal of geriatric psychiatry and neurology 20060301
Title: Galantamine may improve attention and speech in schizophrenia.
Journal: Human psychopharmacology 20060301
Title: Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice.
Journal: Journal of Alzheimer's disease : JAD 20060301
Title: Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month study.
Journal: Clinical therapeutics 20060301
Title: Small vessel disease and subcortical vascular dementia.
Journal: Journal of clinical neurology (Seoul, Korea) 20060301
Title: Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
Journal: The Journal of pharmacology and experimental therapeutics 20060201
Title: Isolation and cholinesterase-inhibition studies of sterols from Haloxylon recurvum.
Journal: Bioorganic & medicinal chemistry letters 20060201
Title: Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the 'blind docking' approach.
Journal: Journal of molecular modeling 20060201
Title: Galantamine for Alzheimer's disease and mild cognitive impairment.
Journal: The Cochrane database of systematic reviews 20060125
Title: Galantamine for vascular cognitive impairment.
Journal: The Cochrane database of systematic reviews 20060125
Title: Cholinesterase inhibitors for Alzheimer's disease.
Journal: The Cochrane database of systematic reviews 20060125
Title: Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060101
Title: Galantamine increases excitability of CA1 hippocampal pyramidal neurons.
Journal: Neuroscience 20060101
Title: Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
Journal: Brain : a journal of neurology 20060101
Title: Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders 20060101
Title: Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis.
Journal: Neurobiology of aging 20060101
Title: A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.
Journal: International journal of geriatric psychiatry 20060101
Title: Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial.
Journal: Psychopharmacology 20060101
Title: Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs.
Journal: International journal of geriatric psychiatry 20060101
Title: Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
Journal: Expert opinion on investigational drugs 20060101
Title: Case of the month: rivastigmine (Exelon) toxicity with evidence of respiratory depression.
Journal: Emergency medicine journal : EMJ 20060101
Title: Circadian cholinergic rhythms: implications for cholinesterase inhibitor therapy.
Journal: Dementia and geriatric cognitive disorders 20060101
Title: Synthesis and pharmacology of galantamine.
Journal: Chemical reviews 20060101
Title: Preventing protein secretion with chemical glue.
Journal: Nature chemical biology 20060101
Title: Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment.
Journal: International journal of clinical practice 20060101
Title: The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
Journal: Health technology assessment (Winchester, England) 20060101
Title: Galantamine-induced QTc prolongation.
Journal: The Journal of clinical psychiatry 20060101
Title: Pharmacological and molecular enhancement of learning in aging and Alzheimer's disease.
Journal: Journal of physiology, Paris 20060101
Title: QEEG monitoring of Alzheimer's disease treatment: a preliminary report of three case studies.
Journal: Clinical EEG and neuroscience 20060101
Title: [Use of reminyl (galantamine) in the treatment of dementia].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20060101
Title: Neuroprotection in vascular dementia.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20060101
Title: Current and emerging pharmacological treatment options for dementia.
Journal: Behavioural neurology 20060101
Title: [Are the prescriptions of anticholinesterasic drugs adapted to the associated diseases and/or drugs in the Alzheimer's dementia?].
Journal: Therapie 20060101
Title: [Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease].
Journal: Neurologia (Barcelona, Spain) 20060101
Title: Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description of hallucinations and delusions in schizophrenia.
Journal: Medical hypotheses 20060101
Title: Galantamine extended release.
Journal: CNS drugs 20060101
Title: Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
Journal: Drugs & aging 20060101
Title: [Optimizing effect of the combined administration of 8-OH-DPAT and galantamine on depression--anxiety behavior in old rats with dementia of Alzheimer's type].
Journal: Eksperimental'naia i klinicheskaia farmakologiia 20060101
Title: Phenomenology and management of cognitive and behavioral disorders in Parkinson's disease. Rise and logic of dementia in Parkinson's disease.
Journal: Annals of general psychiatry 20060101
Title: A systematic review of assessment and treatment of moderate to severe Alzheimer's disease.
Journal: Primary care companion to the Journal of clinical psychiatry 20060101
Title: Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation.
Journal: Current medicinal chemistry 20060101
Title: Galantamine was effective in mild-to-moderate Alzheimer disease.
Journal: ACP journal club 20060101
Title: [Pharmacotherapy for Alzheimer's disease].
Journal: Tijdschrift voor psychiatrie 20060101
Title: Kinetics of 13 new cholinesterase inhibitors.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences 20060101
Title: Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment.
Journal: The Journal of international medical research 20060101
Title: A naturalistic study of galantamine for Alzheimer's disease.
Journal: CNS drugs 20060101
Title: Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics.
Journal: Journal of biomedicine & biotechnology 20060101
Title: Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.
Journal: Journal of biomedicine & biotechnology 20060101
Title: Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes.
Journal: Rapid communications in mass spectrometry : RCM 20060101
Title: Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients.
Journal: Drug safety 20060101
Title: Realistic expectations for treatment success in Alzheimer's disease.
Journal: The journal of nutrition, health & aging 20060101
Title: Galantamine extended release in Alzheimer's disease: profile report.
Journal: Drugs & aging 20060101
Title: Alzheimer disease and its management: a review.
Journal: American journal of therapeutics 20060101
Title: Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
Journal: The American journal of geriatric pharmacotherapy 20060101
Title: The effect of drugs for Alzheimer disease assessed by means of neuroradiological techniques.
Journal: Current medicinal chemistry 20060101
Title: Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation: involvement of the alpha7 nAChR subtype.
Journal: Journal of molecular neuroscience : MN 20060101
Title: The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease.
Journal: Journal of molecular neuroscience : MN 20060101
Title: Galanthamine, a natural product for the treatment of Alzheimer's disease.
Journal: Recent patents on CNS drug discovery 20060101
Title: Neurogenesis and Alzheimer's disease.
Journal: Drug target insights 20060101
Title: Donepezil in Alzheimer's disease: an evidence-based review of its impact on clinical and economic outcomes.
Journal: Core evidence 20060101
Title: Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.
Journal: Journal of medicinal chemistry 20051229
Title: Drug discovery from medicinal plants.
Journal: Life sciences 20051222
Title: Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.
Journal: European journal of pharmacology 20051219
Title: Age-related deficits in the retention of memories for cued fear conditioning are reversed by galantamine treatment.
Journal: Behavioural brain research 20051207
Title: Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells.
Journal: Neuroscience letters 20051202
Title: Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20051201
Title: Pharmacological modulation of cholinergic brain activity and its reflection in special EEG frequency ranges from various brain areas in the freely moving rat (Tele-Stereo-EEG).
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20051201
Title: Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Journal: The Journal of pharmacology and experimental therapeutics 20051201
Title: A case with cholinesterase inhibitor responsive asymmetric posterior cortical atrophy.
Journal: Clinical neurology and neurosurgery 20051201
Title: Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A.
Journal: Journal of natural products 20051201
Title: Galantamine antiacetylcholinesterase activity in rat brain influenced by L-carnitine.
Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20051201
Title: Dementia.
Journal: Clinical evidence 20051201
Title: Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.
Journal: Neuropsychiatric disease and treatment 20051201
Title: Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.
Journal: Brain research 20051109
Title: Mild cognitive impairment: to treat or not to treat.
Journal: Current neurology and neuroscience reports 20051101
Title: Behavioral and neuropsychiatric outcomes in Alzheimer's disease.
Journal: CNS spectrums 20051101
Title: A case report of paranoid delusion with galantamine use.
Journal: Journal of the American Geriatrics Society 20051101
Title: Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease.
Journal: Current medical research and opinion 20051101
Title: Divergent enantioselective synthesis of (-)-galanthamine and (-)-morphine.
Journal: Journal of the American Chemical Society 20051026
Title: Reduction of voluntary ethanol consumption in alcohol-preferring Alko alcohol (AA) rats by desoxypeganine and galanthamine.
Journal: European journal of pharmacology 20051017
Title: Modulation of N-methyl-D-aspartate receptors by donepezil in rat cortical neurons.
Journal: The Journal of pharmacology and experimental therapeutics 20051001
Title: Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury.
Journal: Journal of clinical psychopharmacology 20051001
Title: Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?
Journal: Journal of neurology, neurosurgery, and psychiatry 20051001
Title: Pharmacogenomics and therapeutic prospects in Alzheimer's disease.
Journal: Expert opinion on pharmacotherapy 20051001
Title: Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
Journal: Current medical research and opinion 20051001
Title: New anti-Alzheimer drugs from biodiversity: the role of the natural acetylcholinesterase inhibitors.
Journal: Mini reviews in medicinal chemistry 20051001
Title: Undertreatment of patients with Alzheimer's disease in an elderly United States population.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association 20051001
Title: [Nightmares in patients with Alzheimer's disease caused by donepezil. Therapeutic effect depends on the time of intake].
Journal: Der Nervenarzt 20050901
Title: UK government guidance on Alzheimer's drugs postponed.
Journal: Drug discovery today 20050901
Title: Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.
Journal: Current medical research and opinion 20050901
Title: [Traditional dementia concepts in transition--must we change our views?].
Journal: Der Nervenarzt 20050901
Title: Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum.
Journal: Behavioural brain research 20050830
Title: Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.
Journal: BMJ (Clinical research ed.) 20050806
Title: Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells.
Journal: British journal of pharmacology 20050801
Title: Development of a novel high-concentration galantamine formulation suitable for intranasal delivery.
Journal: Journal of pharmaceutical sciences 20050801
Title: Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity.
Journal: British journal of pharmacology 20050701
Title: A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease.
Journal: European journal of clinical pharmacology 20050701
Title: Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years.
Journal: International journal of clinical practice 20050701
Title: [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
Journal: Tijdschrift voor gerontologie en geriatrie 20050701
Title: Predicting drug metabolism--an evaluation of the expert system METEOR.
Journal: Chemistry & biodiversity 20050701
Title: Acute effects of physostigmine and galantamine on the binding of [18F]fluoro-A-85380: a PET study in monkeys.
Journal: Synapse (New York, N.Y.) 20050615
Title: Indole alkaloids from Tabernaemontana australis (Muell. Arg) Miers that inhibit acetylcholinesterase enzyme.
Journal: Bioorganic & medicinal chemistry 20050602
Title: Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.
Journal: Psychopharmacology 20050601
Title: Quantitative and cytotoxic activity determinations on Galanthus nivalis subsp. cilicicus.
Journal: Fitoterapia 20050601
Title: Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine.
Journal: CNS spectrums 20050601
Title: Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy.
Journal: International journal of geriatric psychiatry 20050601
Title: Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20050601
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology 20050601
Title: [Changing the anticholinesterase in Alzheimer's disease].
Journal: Revista de neurologia 20050601
Title: Galantamine: excess mortality.
Journal: Prescrire international 20050601
Title: Nicotinic agonists, antagonists, and modulators from natural sources.
Journal: Cellular and molecular neurobiology 20050601
Title: Stimulation of nicotinic acetylcholine receptors protects motor neurons.
Journal: Biochemical and biophysical research communications 20050520
Title: Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects.
Journal: Journal of clinical pharmacology 20050501
Title: Switching from donepezil to galantamine: a double-blind study of two wash-out periods.
Journal: International journal of geriatric psychiatry 20050501
Title: Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.
Journal: Archives of neurology 20050501
Title: A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
Journal: Human psychopharmacology 20050401
Title: Capillary electrophoresis-mass spectrometry in impurity profiling of pharmaceutical products.
Journal: Electrophoresis 20050401
Title: [Cost-effectiveness of galantamine in a german context].
Journal: Psychiatrische Praxis 20050401
Title: Actions of tacrine and galanthamine on histamine-N-methyltransferase.
Journal: Methods and findings in experimental and clinical pharmacology 20050401
Title: Pharmacokinetic simulation for switching from galantamine immediate-release to extended-release formulation.
Journal: Current medical research and opinion 20050401
Title: [Determination of galanthamine in bulb of Lycoris radiata by RP-HPLC].
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20050401
Title: Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
Journal: The Journal of pharmacology and experimental therapeutics 20050301
Title: Cholinesterase inhibitors in the treatment of dementia.
Journal: The Journal of the American Osteopathic Association 20050301
Title: Pharmacologic treatment options in Alzheimer's disease: optimizing disease management.
Journal: Journal of the American Academy of Nurse Practitioners 20050301
Title: Mild cognitive impairment in Parkinson's disease: the challenge and the promise.
Journal: Neuropsychiatric disease and treatment 20050301
Title: Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
Journal: Journal of medicinal chemistry 20050224
Title: Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20050223
Title: Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
Journal: European journal of pharmacology 20050221
Title: Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
Journal: Brain research 20050208
Title: Regulatory authorities review use of galantamine in mild cognitive impairment.
Journal: BMJ (Clinical research ed.) 20050205
Title: Butyrylcholinesterase inhibitory guaianolides from Amberboa ramosa.
Journal: Archives of pharmacal research 20050201
Title: [Acetylcholinesterase inhibitor treatment for Alzheimer's disease: the experience in Picardy].
Journal: Revue neurologique 20050201
Title: Indicators of neuroprotection with galantamine.
Journal: Brain research bulletin 20050130
Title: Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats.
Journal: Behavioural brain research 20050106
Title: Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20050101
Title: Not all head-to-head trials are created equal: results from an open-label, short-term study seem inconsistent with previous donepezil literature.
Journal: International journal of geriatric psychiatry 20050101
Title: Look-alike, sound-alike drug errors with Reminyl and Amaryl.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050101
Title: Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
Journal: Dementia and geriatric cognitive disorders 20050101
Title: [Treatment of dementia].
Journal: Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20050101
Title: Integrated treatment approach improves cognitive function in demented and clinically depressed patients.
Journal: American journal of Alzheimer's disease and other dementias 20050101
Title: Portals to Wonderland: health portals lead to confusing information about the effects of health care.
Journal: BMC medical informatics and decision making 20050101
Title: Cholinesterase inhibitor affects the amyloid precursor protein isoforms in patients with Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders 20050101
Title: Metabolites from Microsphaeropsis olivacea, an endophytic fungus of Pilgerodendron uviferum.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences 20050101
Title: CGC-MS of alkaloids in Leucojum aestivum plants and their in vitro cultures.
Journal: Phytochemical analysis : PCA 20050101
Title: Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease.
Journal: Neuro-Signals 20050101
Title: The effect of galantamine added to clozapine on cognition of five patients with schizophrenia.
Journal: Clinical neuropharmacology 20050101
Title: [Pharmacology of Alzheimer's disease: where do we go from here?].
Journal: Therapie 20050101
Title: Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders 20050101
Title: Treating patients with moderate to severe Alzheimer's disease: implications of recent pharmacologic studies.
Journal: Primary care companion to the Journal of clinical psychiatry 20050101
Title: Drug therapy of dementia in elderly patients. A review.
Journal: Nordic journal of psychiatry 20050101
Title: Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study.
Journal: American journal of Alzheimer's disease and other dementias 20050101
Title: [Reminyl efficacy in dementia with Levi bodies].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101
Title: Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study.
Journal: Alzheimer disease and associated disorders 20050101
Title: Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.
Journal: PharmacoEconomics 20050101
Title: Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies.
Journal: The Journal of neuropsychiatry and clinical neurosciences 20050101
Title: [Use of acetylcholinesterase inhibitors and memantine in Alzheimer-type dementia].
Journal: Revista espanola de salud publica 20050101
Title: Guidelines for the treatment of Alzheimer's disease from the Italian Association of Psychogeriatrics.
Journal: Drugs & aging 20050101
Title: The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Journal: Postgraduate medicine 20050101
Title: Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity.
Journal: Biochemical and biophysical research communications 20041217
Title: Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products.
Journal: Journal of medicinal chemistry 20041202
Title: The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
Journal: Journal of the American Chemical Society 20041201
Title: Novel neuronal targets for the acetylcholinesterase inhibitor donepezil.
Journal: Neuropharmacology 20041201
Title: Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study.
Journal: NeuroImage 20041201
Title: Adjuvant therapeutic effects of galantamine on apathy in a schizophrenia patient.
Journal: The Journal of clinical psychiatry 20041201
Title: Improved production of galanthamine and related alkaloids by methyl jasmonate in Narcissus confusus shoot-clumps.
Journal: Planta medica 20041201
Title: Dementia.
Journal: Clinical evidence 20041201
Title: Pharmacotherapy of mild cognitive impairment.
Journal: Dialogues in clinical neuroscience 20041201
Title: Mild cognitive impairment: historical development and summary of research.
Journal: Dialogues in clinical neuroscience 20041201
Title: Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels.
Journal: Brain research. Molecular brain research 20041124
Title: Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
Journal: Journal of the neurological sciences 20041115
Title: Switching from donepezil or rivastigmine to galantamine in clinical practice.
Journal: Journal of the American Geriatrics Society 20041101
Title: Mechanisms of action of cognitive enhancers on neuroreceptors.
Journal: Biological & pharmaceutical bulletin 20041101
Title: Isolation of the acetylcholinesterase inhibitor ungeremine from Nerine bowdenii by preparative HPLC coupled on-line to a flow assay system.
Journal: Biological & pharmaceutical bulletin 20041101
Title: Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
Journal: European journal of neurology 20041101
Title: An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.
Journal: Current medical research and opinion 20041101
Title: Effects of galantamine in patients with mild Alzheimer's disease.
Journal: Current medical research and opinion 20041101
Title: Indole glucoalkaloids from Chimarrhis turbinata and their evaluation as antioxidant agents and acetylcholinesterase inhibitors.
Journal: Journal of natural products 20041101
Title: Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20041101
Title: [Natural progression of Alzheimer's disease (AD): a perspective on possible therapies for advanced AD].
Journal: Rinsho shinkeigaku = Clinical neurology 20041101
Title: Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Journal: European journal of pharmacology 20041025
Title: Galantamine for Alzheimer's disease.
Journal: The Cochrane database of systematic reviews 20041018
Title: Acetylcholinesterase inhibitors: novel activities of old molecules.
Journal: Pharmacological research 20041001
Title: Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20041001
Title: Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
Journal: Movement disorders : official journal of the Movement Disorder Society 20041001
Title: Cognitive dysfunction and dementia in Parkinson's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20041001
Title: Xanthones from Gentiana campestris as new acetylcholinesterase inhibitors.
Journal: Planta medica 20041001
Title: A prospective, double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population.
Journal: Clinical therapeutics 20041001
Title: In vivo and in vitro study of the influence of the anticholinesterase drug galantamine on motor and evacuative functions of rat gastrointestinal tract.
Journal: European journal of pharmacology 20040913
Title: Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial.
Journal: JAMA 20040908
Title: Pharmacotherapy of chronic fatigue syndrome: another gallant attempt.
Journal: JAMA 20040908
Title: Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons.
Journal: The Journal of pharmacology and experimental therapeutics 20040901
Title: Evidence-based pharmacotherapy of Alzheimer's disease.
Journal: The international journal of neuropsychopharmacology 20040901
Title: Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
Journal: Neuropharmacology 20040901
Title: Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release.
Journal: Molecular pharmacology 20040901
Title: Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons.
Journal: Molecular pharmacology 20040901
Title: The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
Journal: Expert opinion on drug safety 20040901
Title: Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase.
Journal: Neuropharmacology 20040901
Title: Dementia in idiopathic Parkinson's syndrome.
Journal: Journal of neurology 20040901
Title: Behavioral disturbances in Parkinson's disease.
Journal: Dialogues in clinical neuroscience 20040901
Title: Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120.
Journal: Brain research bulletin 20040830
Title: Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons.
Journal: Experimental neurology 20040801
Title: Donepezil is more effective than galantamine for mild to moderate Alzheimer's disease.
Journal: Evidence-based mental health 20040801
Title: [Drug-cholinesterase-inhibitors persistence patterns in treated patients with dementia of Alzheimer type: retrospective comparative analysis of donepezil, rivastigmine and galantamine].
Journal: Revista de neurologia 20040801
Title: Gastrointestinal adverse events in a general population sample of nursing home residents taking cholinesterase inhibitors.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20040801
Title: Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation.
Journal: Neuroscience letters 20040722
Title: A case study in the treatment of dementia with Lewy bodies.
Journal: Acta psychiatrica Scandinavica 20040701
Title: Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease.
Journal: Journal of the American Geriatrics Society 20040701
Title: What is the rationale for new treatment strategies in Alzheimer's disease?
Journal: CNS spectrums 20040701
Title: Understanding the latest advances in pharmacologic interventions for Alzheimer's disease.
Journal: CNS spectrums 20040701
Title: Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
Journal: Neurological research 20040701
Title: [Galantamine, an acetylcholinesterase inhibitor with various actions].
Journal: Medizinische Monatsschrift fur Pharmazeuten 20040701
Title: Effects of galantamine, a nicotinic allosteric potentiating ligand, on nicotine-induced catecholamine release in hippocampus and nucleus accumbens of rats.
Journal: The Journal of pharmacology and experimental therapeutics 20040601
Title: Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge.
Journal: Journal of ethnopharmacology 20040601
Title: Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.
Journal: Current medical research and opinion 20040601
Title: Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists.
Journal: Psychopharmacology 20040601
Title: Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
Journal: International journal of geriatric psychiatry 20040601
Title: Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01).
Journal: Arquivos de neuro-psiquiatria 20040601
Title: ApoE genotyping and response to galanthamine in Alzheimer's disease--a real life retrospective study.
Journal: Collegium antropologicum 20040601
Title: Dementia.
Journal: Clinical evidence 20040601
Title: [Current antidementive therapy].
Journal: MMW Fortschritte der Medizin 20040524
Title: Total synthesis of (-)-galanthamine by remote asymmetric induction.
Journal: Angewandte Chemie (International ed. in English) 20040510
Title: The clinical efficacy and safety of galantamine in the treatment of Alzheimer's disease.
Journal: CNS spectrums 20040501
Title: Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.
Journal: Clinical therapeutics 20040501
Title: [Current therapies in dementia].
Journal: Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20040501
Title: Drug therapy for Alzheimer's disease.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20040427
Title: Emerging therapies for vascular dementia and vascular cognitive impairment.
Journal: Stroke 20040401
Title: Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease.
Journal: Current medical research and opinion 20040401
Title: Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease.
Journal: The American journal of psychiatry 20040301
Title: Intraspecific variability in the alkaloid metabolism of Galanthus elwesii.
Journal: Phytochemistry 20040301
Title: Galantamine: use in Alzheimer's disease and related disorders.
Journal: Expert review of neurotherapeutics 20040301
Title: The use of zebrafish mutants to identify secondary target effects of acetylcholine esterase inhibitors.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20040201
Title: The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial.
Journal: Archives of neurology 20040201
Title: A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease.
Journal: International journal of clinical practice 20040201
Title: Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamine.
Journal: Dementia and geriatric cognitive disorders 20040101
Title: Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders 20040101
Title: Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes.
Journal: Neuropharmacology 20040101
Title: Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors.
Journal: Neuropharmacology 20040101
Title: Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
Journal: Dementia and geriatric cognitive disorders 20040101
Title: Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis.
Journal: Dementia and geriatric cognitive disorders 20040101
Title: A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.
Journal: International journal of geriatric psychiatry 20040101
Title: Cholinesterase inhibitors and vascular dementia: another string to their bow?
Journal: CNS drugs 20040101
Title: Galantamine facilitates acquisition of hippocampus-dependent trace eyeblink conditioning in aged rabbits.
Journal: Learning & memory (Cold Spring Harbor, N.Y.) 20040101
Title: Galantamine facilitates acquisition of a trace-conditioned eyeblink response in healthy, young rabbits.
Journal: Learning & memory (Cold Spring Harbor, N.Y.) 20040101
Title: Acetylcholinesterase inhibition in Alzheimer's Disease.
Journal: Current pharmaceutical design 20040101
Title: Pharmacokinetics and tissue distribution of galantamine and galantamine-related radioactivity after single intravenous and oral administration in the rat.
Journal: Arzneimittel-Forschung 20040101
Title: Treatment of Huntington's disease with galantamine.
Journal: International clinical psychopharmacology 20040101
Title: Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Journal: Drugs & aging 20040101
Title: [Drug therapy for aged patients with Alzheimer disease].
Journal: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20040101
Title: [The virtual synapse what is its contribution to understanding cholinergic neural transmission?].
Journal: Therapie 20040101
Title: Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a 'real world' study.
Journal: Archives of gerontology and geriatrics. Supplement 20040101
Title: What are the treatment options for patients with severe Alzheimer's disease?
Journal: CNS drugs 20040101
Title: The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available?
Journal: Journal of the American Medical Directors Association 20040101
Title: Wernicke-Korsakoff syndrome and galantamine.
Journal: Psychosomatics 20040101
Title: Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.
Journal: Dementia and geriatric cognitive disorders 20040101
Title: Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20040101
Title: Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitors.
Journal: Alzheimer disease and associated disorders 20040101
Title: Noncognitive symptoms and long-term treatment expectations for Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20040101
Title: The needs of the caregiver in the long-term treatment of Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20040101
Title: The economic benefits of acetylcholinesterase inhibitors for patients with Alzheimer disease and associated dementias.
Journal: Alzheimer disease and associated disorders 20040101
Title: Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries.
Journal: Drugs & aging 20040101
Title: Long-term outcomes of galantamine treatment in patients with Alzheimer disease.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20040101
Title: Alleviation of multiple abnormalities by galantamine treatment in two patients with dementia with Lewy bodies.
Journal: American journal of Alzheimer's disease and other dementias 20040101
Title: Long-term cholinesterase inhibitor treatment of Alzheimer's disease.
Journal: CNS drugs 20040101
Title: An overview of the current and novel drugs for Alzheimer's disease with particular reference to anti-cholinesterase compounds.
Journal: Current pharmaceutical design 20040101
Title: Development of bivalent acetylcholinesterase inhibitors as potential therapeutic drugs for Alzheimer's disease.
Journal: Current pharmaceutical design 20040101
Title: New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease.
Journal: Current pharmaceutical design 20040101
Title: Molecular recognition between 4a S/R-galanthamine diastereoisomers and alpha-cyclodextrin.
Journal: Journal of molecular modeling 20031201
Title: Antimalarial activity screening of some alkaloids and the plant extracts from Amaryllidaceae.
Journal: Phytotherapy research : PTR 20031201
Title: Galanthamine distribution in Bulgarian Galanthus spp.
Journal: Die Pharmazie 20031201
Title: Galanthamine pattern in Narcissus confusus plants.
Journal: Planta medica 20031201
Title: A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD 20031201
Title: Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
Journal: Prescrire international 20031201
Title: Modulation of cholinergic transmission enhances excitability of hippocampal pyramidal neurons and ameliorates learning impairments in aging animals.
Journal: Neurobiology of learning and memory 20031101
Title: The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
Journal: Molecular pharmacology 20031101
Title: Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease.
Journal: European journal of neurology 20031101
Title: Editorial comment--How to treat vascular dementia?
Journal: Stroke 20031001
Title: Treatment of dementia with neurotransmission modulation.
Journal: Expert opinion on investigational drugs 20031001
Title: Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
Journal: International journal of geriatric psychiatry 20031001
Title: The effects of galantamine treatment on caregiver time in Alzheimer's disease.
Journal: International journal of geriatric psychiatry 20031001
Title: Pharmacologic treatment of Alzheimer's disease: an update.
Journal: American family physician 20031001
Title: Modulation of MK-801-elicited mouse popping behavior by galantamine is complex and dose-dependent.
Journal: Life sciences 20030919
Title: Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030916
Title: (-)-9-Dehydrogalanthaminium bromide, a new cholinesterase inhibitor, enhances place and object recognition memory in young and old rats.
Journal: Neurobiology of learning and memory 20030901
Title: Treatment of Alzheimer's disease: current status and new perspectives.
Journal: The Lancet. Neurology 20030901
Title: Update on Alzheimer drugs (galantamine).
Journal: The neurologist 20030901
Title: Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
Journal: International journal of geriatric psychiatry 20030901
Title: Combination pharmacotherapy in Alzheimer's disease.
Journal: Dialogues in clinical neuroscience 20030901
Title: Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons.
Journal: The Journal of pharmacology and experimental therapeutics 20030801
Title: Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK.
Journal: International journal of geriatric psychiatry 20030801
Title: Alzheimer's disease: the pharmacological pathway.
Journal: Fundamental & clinical pharmacology 20030801
Title: Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine.
Journal: Sleep 20030801
Title: Synthesis and structure-activity relationships of open D-Ring galanthamine analogues.
Journal: Bioorganic & medicinal chemistry letters 20030721
Title: Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation.
Journal: European journal of pharmacology 20030704
Title: [Acetylcholinesterase inhibitors].
Journal: Revue medicale de la Suisse romande 20030701
Title: Development and validation of a liquid chromatographic-tandem mass spectrometric method for the determination of galantamine in human heparinised plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030615
Title: Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
Journal: The Journal of pharmacology and experimental therapeutics 20030601
Title: An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia.
Journal: Clinical therapeutics 20030601
Title: Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States.
Journal: Clinical therapeutics 20030601
Title: Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function.
Journal: Pharmacology, biochemistry, and behavior 20030601
Title: Dementia.
Journal: Clinical evidence 20030601
Title: The impact of drugs against dementia on cognition in aging and mild cognitive impairment.
Journal: Pharmacopsychiatry 20030601
Title: [Current therapy of patients with dementia].
Journal: MMW Fortschritte der Medizin 20030526
Title: Synthesis, anticholinesterase activity and structure-activity relationships of m-Aminobenzoic acid derivatives.
Journal: Bioorganic & medicinal chemistry letters 20030519
Title: Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20030513
Title: Extended lifetime of reagentless detector for multiple inhibitors of acetylcholinesterase.
Journal: Biosensors & bioelectronics 20030501
Title: Galantamine population pharmacokinetics in patients with Alzheimer's disease: modeling and simulations.
Journal: Journal of clinical pharmacology 20030501
Title: Galantamine.
Journal: The Israel Medical Association journal : IMAJ 20030501
Title: The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure.
Journal: International journal of geriatric psychiatry 20030401
Title: Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20030401
Title: Galantamine: a review of its use in Alzheimer's disease and vascular dementia.
Journal: International journal of clinical practice 20030401
Title: Sequential designs for phase III clinical trials incorporating treatment selection.
Journal: Statistics in medicine 20030315
Title: Galantamine hydrobromide: an agent for Alzheimer's disease.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030301
Title: Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?
Journal: Dialogues in clinical neuroscience 20030301
Title: The evaluation of cognitive function in the dementias: methodological and regulatory considerations.
Journal: Dialogues in clinical neuroscience 20030301
Title: Treatment of cognitive impairment in Alzheimer's disease.
Journal: Dialogues in clinical neuroscience 20030301
Title: Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20030201
Title: Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease.
Journal: Stroke 20030201
Title: Galantamine blocks delayed rectifier, but not transient outward potassium current in rat dissociated hippocampal pyramidal neurons.
Journal: Neuroscience letters 20030109
Title: Patterns of clinically detectable treatment effects with galantamine: a qualitative analysis.
Journal: Dementia and geriatric cognitive disorders 20030101
Title: Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.
Journal: British journal of pharmacology 20030101
Title: Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders.
Journal: Phytotherapy research : PTR 20030101
Title: Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months.
Journal: Dementia and geriatric cognitive disorders 20030101
Title: Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20030101
Title: Impact of study design and patient population on outcomes from cholinesterase inhibitor trials.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20030101
Title: Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors.
Journal: Neuroscience 20030101
Title: Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography.
Journal: Phytochemical analysis : PCA 20030101
Title: Determining acetylcholinesterase inhibitory activity in plant extracts using a fluorimetric flow assay.
Journal: Phytochemical analysis : PCA 20030101
Title: Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20030101
Title: Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20030101
Title: Nicotinic receptors and Alzheimer's disease.
Journal: Current medical research and opinion 20030101
Title: [Zoofilia as late complication of Parkinson's disease. Circe drugs and Mercury antidotes].
Journal: Neurologia (Barcelona, Spain) 20030101
Title: Antioxidant properties of galantamine hydrobromide.
Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences 20030101
Title: A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
Journal: Drugs & aging 20030101
Title: Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.
Journal: Arzneimittel-Forschung 20030101
Title: Current treatments for Alzheimer's disease: cholinesterase inhibitors.
Journal: The Journal of clinical psychiatry 20030101
Title: Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
Journal: CNS drugs 20030101
Title: Galantamine demonstrates efficacy and safety in elderly patients with Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20030101
Title: Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.
Journal: CNS drugs 20030101
Title: Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
Journal: Acta biologica Hungarica 20030101
Title: Clinical experience of galantamine in dementia: a series of case reports.
Journal: Current medical research and opinion 20030101
Title: Capillary electrophoresis as an orthogonal technique in HPLC method validation.
Journal: Journal of capillary electrophoresis and microchip technology 20030101
Title: The pharmacist's role in managing patients with Alzheimer's disease.
Journal: Journal of the American Pharmacists Association : JAPhA 20030101
Title: [Mechanisms of action of Alzheimer medications].
Journal: Duodecim; laaketieteellinen aikakauskirja 20030101
Title: Galantamine vs donepezil in the treatment of Alzheimer's disease.
Journal: Drugs & aging 20030101
Title: Clinical pharmacokinetics of galantamine.
Journal: Clinical pharmacokinetics 20030101
Title: Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis.
Journal: BMC geriatrics 20030101
Title: [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101
Title: Galantamine in the treatment of adult autism: a report of three clinical cases.
Journal: International journal of psychiatry in medicine 20030101
Title: Galantamine in the treatment of vascular dementia.
Journal: International psychogeriatrics 20030101
Title: Galantamine may be effective in treating autistic disorder.
Journal: BMJ (Clinical research ed.) 20021214
Title: Enantioselective synthesis of (-)-codeine and (-)-morphine.
Journal: Journal of the American Chemical Society 20021211
Title: [Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office].
Journal: Fortschritte der Medizin. Originalien 20021205
Title: Unconventional ligands and modulators of nicotinic receptors.
Journal: Journal of neurobiology 20021201
Title: Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together.
Journal: Journal of clinical pharmacology 20021201
Title: Treatment options: the latest evidence with galantamine (Reminyl).
Journal: Journal of the neurological sciences 20021115
Title: The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease.
Journal: Journal of the neurological sciences 20021115
Title: Use of galantamine to treat vascular dementia.
Journal: Lancet (London, England) 20021109
Title: Use of galantamine to treat vascular dementia.
Journal: Lancet (London, England) 20021109
Title: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
Journal: Current neurology and neuroscience reports 20021101
Title: [Treatment of Alzheimer's disease].
Journal: Revista de neurologia 20021101
Title: [Rivastigmine: a review of its clinical effectiveness].
Journal: Revista de neurologia 20021101
Title: Progress in clinical neurosciences: Treatment of Alzheimer's disease and other dementias--review and comparison of the cholinesterase inhibitors.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20021101
Title: A novel treatment for patients with Alzheimer's disease and with vascular dementia.
Journal: Annals of the New York Academy of Sciences 20021101
Title: Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease treated with galantamine.
Journal: Annals of the New York Academy of Sciences 20021101
Title: [Anti-dementia drugs for Alzheimer disease in present and future].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20021101
Title: A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat.
Journal: European journal of pharmacology 20021025
Title: Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts.
Journal: Life sciences 20021011
Title: The impact of journal advertisements on prescribers of cholinesterase inhibitors.
Journal: International journal of geriatric psychiatry 20021001
Title: [Galantamine: a novel cholinergic agent for Alzheimer's disease].
Journal: Neurologia (Barcelona, Spain) 20021001
Title: Bioactive constituents from Iryanthera megistophylla.
Journal: Journal of natural products 20021001
Title: Cognitive pharmacotherapy of Alzheimer's disease and other dementias.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie 20021001
Title: [The role of substantia nigra in the cognitive activity in cats].
Journal: Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20021001
Title: Quaternary salts of E2020 analogues as acetylcholinesterase inhibitors for the reversal of neuromuscular block.
Journal: Bioorganic & medicinal chemistry letters 20020916
Title: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
Journal: Current neurology and neuroscience reports 20020901
Title: Galantamine pharmacokinetics, safety, and tolerability profiles are similar in healthy Caucasian and Japanese subjects.
Journal: Journal of clinical pharmacology 20020901
Title: Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine.
Journal: European journal of neurology 20020901
Title: Galantamine provides broad benefits in patients with 'advanced moderate' Alzheimer's disease (MMSE < or = 12) for up to six months.
Journal: International journal of clinical practice 20020901
Title: Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20020901
Title: Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.
Journal: Journal of medicinal chemistry 20020815
Title: An efficient enantioselective synthesis of (-)-galanthamine.
Journal: Angewandte Chemie (International ed. in English) 20020802
Title: Galantamine for vascular dementia.
Journal: The Lancet. Neurology 20020801
Title: Galantamine for treatment-resistant schizophrenia.
Journal: The American journal of psychiatry 20020701
Title: Medical treatment of Alzheimer's disease: past, present, and future.
Journal: Medicine and health, Rhode Island 20020701
Title: [Nicotinic Receptor, galantamine and Alzheimer disease].
Journal: Revista de neurologia 20020601
Title: The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
Journal: International journal of clinical practice. Supplement 20020601
Title: The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.
Journal: International journal of clinical practice. Supplement 20020601
Title: Evidence that the clinical effects of cholinesterase inhibitors are related to potency and targeting of action.
Journal: International journal of clinical practice. Supplement 20020601
Title: Switching cholinesterase inhibitors in patients with Alzheimer's disease.
Journal: International journal of clinical practice. Supplement 20020601
Title: Galanthamine as bis-functional ligand for the acetylcholinesterase.
Journal: Journal of molecular modeling 20020601
Title: [Latest therapies for treating dementia].
Journal: Atencion primaria 20020515
Title: [Dementing disorders. What benefits do the new anti-dementia drugs have?].
Journal: MMW Fortschritte der Medizin 20020506
Title: The metabolism and excretion of galantamine in rats, dogs, and humans.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20020501
Title: The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system.
Journal: Molecular pharmacology 20020501
Title: Pharmacologic treatments of dementia.
Journal: The Medical clinics of North America 20020501
Title: Galantamine for vascular dementia: some answers, some questions.
Journal: Lancet (London, England) 20020413
Title: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.
Journal: Lancet (London, England) 20020413
Title: Pharmacokinetics and safety of galantamine in subjects with hepatic impairment and healthy volunteers.
Journal: Journal of clinical pharmacology 20020401
Title: Pd asymmetric allylic alkylation (AAA). A powerful synthetic tool.
Journal: Chemical & pharmaceutical bulletin 20020101
Title: A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase inhibitors in plants.
Journal: Phytochemical analysis : PCA 20020101
Title: A non-cholinergic, trophic action of acetylcholinesterase on hippocampal neurones in vitro: molecular mechanisms.
Journal: Neuroscience 20020101
Title: Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.
Journal: Current medical research and opinion 20020101
Title: Cholinergic medication for neuroleptic-induced tardive dyskinesia.
Journal: The Cochrane database of systematic reviews 20020101
Title: Galantamine for Alzheimer's disease.
Journal: The Cochrane database of systematic reviews 20020101
Title: Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden.
Journal: PharmacoEconomics 20020101
Title: Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands.
Journal: Dementia and geriatric cognitive disorders 20020101
Title: [New theory! Galantamine and nicotinic-cholinergic transmission].
Journal: Pharmazie in unserer Zeit 20020101
Title: Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
Journal: Clinical pharmacokinetics 20020101
Title: Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease.
Journal: CNS drug reviews 20020101
Title: To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers?
Journal: BMC neurology 20020101
Title: New drugs 2002, part 1.
Journal: Nursing 20020101
Title: Galantamine: a pharmacoeconomic review of its use in Alzheimer's disease.
Journal: PharmacoEconomics 20020101
Title: Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review.
Journal: International journal of technology assessment in health care 20020101
Title: Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia.
Journal: Clinical neuropharmacology 20020101
Title: Galantamine improved cognition and global functioning in vascular dementia or Alzheimer disease with cerebrovascular disease.
Journal: ACP journal club 20020101
Title: The cholinergic approach for the treatment of vascular dementia: evidence from pre-clinical and clinical studies.
Journal: Clinical and experimental hypertension (New York, N.Y. : 1993) 20020101
Title: Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy.
Journal: Journal of neural transmission. Supplementum 20020101
Title: Nicotinic cholinergic modulation: galantamine as a prototype.
Journal: CNS drug reviews 20020101
Title: Vascular dementia: galantamine (Reminyl) as an emerging therapeutic option.
Journal: Acta neurologica Scandinavica. Supplementum 20020101
Title: Cognitive decline and treatment options for patients with vascular dementia.
Journal: Acta neurologica Scandinavica. Supplementum 20020101
Title: Non-cognitive benefits of galantamine (Reminyl) treatment in vascular dementia.
Journal: Acta neurologica Scandinavica. Supplementum 20020101
Title: Solid-phase extraction and reversed-phase high-performance liquid chromatography of the five major alkaloids in Narcissus confusus.
Journal: Phytochemical analysis : PCA 20020101
Title: The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients.
Journal: International psychogeriatrics 20020101
Title: The ABC of Alzheimer's disease: behavioral symptoms and their treatment.
Journal: International psychogeriatrics 20020101
Title: A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
Journal: International psychogeriatrics 20020101
Title: [Acetylcholinesterase inhibitors--beyond Alzheimer's disease].
Journal: Psychiatria polska 20020101
Title: [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
Journal: MMW Fortschritte der Medizin 20011213
Title: Unsafe prescription medication switching recommendations.
Journal: Clinical therapeutics 20011201
Title: Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease.
Journal: Prescrire international 20011201
Title: Current status and new developments with galantamine in the treatment of Alzheimer's disease.
Journal: Expert opinion on pharmacotherapy 20011201
Title: [Perspectives for drug treatment in Alzheimer's disease].
Journal: Annales de medecine interne 20011201
Title: Galantamine hydrobromide.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011115
Title: Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.
Journal: Journal of neurology, neurosurgery, and psychiatry 20011101
Title: Galantamine: a new alzheimer drug with a past life.
Journal: The Annals of pharmacotherapy 20011101
Title: Galantamine: a new treatment for Alzheimer's disease.
Journal: Expert review of neurotherapeutics 20011101
Title: Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada.
Journal: Neurology 20010925
Title: Sleep and the cholinergic rapid eye movement sleep induction test in patients with primary alcohol dependence.
Journal: Biological psychiatry 20010901
Title: Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease.
Journal: International journal of geriatric psychiatry 20010901
Title: [Anticholinesterase agents in Alzheimer's disease].
Journal: Revue medicale de Bruxelles 20010901
Title: Use of acetylcholinesterase inhibitors in Alzheimer's disease.
Journal: Expert review of neurotherapeutics 20010901
Title: Therapeutic approaches to age-associated neurocognitive disorders.
Journal: Dialogues in clinical neuroscience 20010901
Title: Medications for the treatment of Alzheimer's disease.
Journal: The Journal of the Oklahoma State Medical Association 20010801
Title: Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20010801
Title: Maintaining cognitive function in Alzheimer disease: how effective are current treatments?
Journal: Alzheimer disease and associated disorders 20010801
Title: Maintaining functional and behavioral abilities in Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20010801
Title: Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product.
Journal: Journal of the American Chemical Society 20010711
Title: Use of cholinesterase inhibitors for treatment of Alzheimer disease.
Journal: Cleveland Clinic journal of medicine 20010701
Title: Featured CME topic: dementia. Medication update.
Journal: Southern medical journal 20010701
Title: Galantamine (reminyl) for Alzheimer's disease.
Journal: The Medical letter on drugs and therapeutics 20010625
Title: Alzheimer's disease and related disorders.
Journal: The Medical clinics of North America 20010501
Title: Meeting the challenges of vascular dementia. Introduction.
Journal: International journal of clinical practice. Supplement 20010501
Title: The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).
Journal: International journal of clinical practice. Supplement 20010501
Title: Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining.
Journal: Journal of chromatography. A 20010427
Title: FDA approves galantamine for Alzheimer's disease.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010415
Title: Muscarinic agonists and antagonists in the treatment of Alzheimer's disease.
Journal: Farmaco (Societa chimica italiana : 1989) 20010401
Title: Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease.
Journal: Neuroscience letters 20010316
Title: Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20010213
Title: Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs.
Journal: Proteins 20010201
Title: Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease.
Journal: Biological psychiatry 20010201
Title: Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease.
Journal: Biological psychiatry 20010201
Title: APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders 20010101
Title: Cholinesterase inhibitors for Alzheimer's disease.
Journal: Drugs 20010101
Title: Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
Journal: Health technology assessment (Winchester, England) 20010101
Title: Galantamine for Alzheimer's disease.
Journal: The Cochrane database of systematic reviews 20010101
Title: Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Introduction.
Journal: Clinical therapeutics 20010101
Title: Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine.
Journal: Clinical therapeutics 20010101
Title: Effects of washout and dose-escalation periods on the efficacy, safety, and tolerability of galantamine in patients previously treated with donepezil: ongoing clinical trials.
Journal: Clinical therapeutics 20010101
Title: Switching previous therapies for Alzheimer's disease to galantamine.
Journal: Clinical therapeutics 20010101
Title: Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers.
Journal: Clinical therapeutics 20010101
Title: Pharmacokinetic rationale for switching from donepezil to galantamine.
Journal: Clinical therapeutics 20010101
Title: Galantamine introduced in Europe.
Journal: American journal of Alzheimer's disease and other dementias 20010101
Title: Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking.
Journal: Journal of molecular graphics & modelling 20010101
Title: Newest developments in dementia treatment and prevention.
Journal: Geriatric nursing (New York, N.Y.) 20010101
Title: Galantamine for Alzheimer's disease.
Journal: The Cochrane database of systematic reviews 20010101
Title: Drugs used for cognitive symptoms of Alzheimer's disease.
Journal: Perspectives in psychiatric care 20010101
Title: Galantamine: a review of its use in Alzheimer's disease.
Journal: Drugs 20001101
Title: Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution.
Journal: FEBS letters 19991217
Title: [The selectivity of the action of muscarinic agonists in vivo].
Journal: Eksperimental'naia i klinicheskaia farmakologiia 19940101
Title: Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats.
Journal: Psychopharmacology 19920101
Title: Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).
Journal: Der Anaesthesist 19771201
Title: Melanie-Jayne R. Howes, et al. Acetylcholinesterase inhibitors of natural origin. International Journal of Research in Pharmaceutical and Biomedical Sciences 3(SI 1):67-86.
Title: Kuryatov A, et al. Roles of accessory subunits in alpha4beta2(*) nicotinic receptors. Mol Pharmacol. 2008 Jul;74(1):132-43.
Title: Kita Y, et al. Galantamine increases hippocampal insulin-like growth factor 2 expression via α7 nicotinic acetylcholine receptors in mice. Psychopharmacology (Berl). 2013 Feb;225(3):543-51.
